<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">35057544</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>26</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2072-6643</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>2</Issue><PubDate><Year>2022</Year><Month>Jan</Month><Day>15</Day></PubDate></JournalIssue><Title>Nutrients</Title><ISOAbbreviation>Nutrients</ISOAbbreviation></Journal><ArticleTitle>In Vitro Methodologies to Study the Role of Advanced Glycation End Products (AGEs) in Neurodegeneration.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">363</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/nu14020363</ELocationID><Abstract><AbstractText>Advanced glycation end products (AGEs) can be present in food or be endogenously produced in biological systems. Their formation has been associated with chronic neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, and amyotrophic lateral sclerosis. The implication of AGEs in neurodegeneration is related to their ability to bind to AGE-specific receptors and the ability of their precursors to induce the so-called "dicarbonyl stress", resulting in cross-linking and protein damage. However, the mode of action underlying their role in neurodegeneration remains unclear. While some research has been carried out in observational clinical studies, further in vitro studies may help elucidate these underlying modes of action. This review presents and discusses in vitro methodologies used in research on the potential role of AGEs in neuroinflammation and neurodegeneration. The overview reveals the main concepts linking AGEs to neurodegeneration, the current findings, and the available and advisable in vitro models to study their role. Moreover, the major questions regarding the role of AGEs in neurodegenerative diseases and the challenges and discrepancies in the research field are discussed.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chrysanthou</LastName><ForeName>Marialena</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-4847-0813</Identifier><AffiliationInfo><Affiliation>Department of Food Chemistry, Wageningen University and Research, Bornse Weilanden 9, 6708 WG Wageningen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miro Estruch</LastName><ForeName>Ignacio</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Toxicology, Wageningen University and Research, Stippeneng 4, 6708 WE Wageningen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rietjens</LastName><ForeName>Ivonne M C M</ForeName><Initials>IMCM</Initials><AffiliationInfo><Affiliation>Department of Toxicology, Wageningen University and Research, Stippeneng 4, 6708 WE Wageningen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wichers</LastName><ForeName>Harry J</ForeName><Initials>HJ</Initials><Identifier Source="ORCID">0000-0002-8030-7090</Identifier><AffiliationInfo><Affiliation>Department of Food Chemistry, Wageningen University and Research, Bornse Weilanden 9, 6708 WG Wageningen, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Food and Biobased Research, Wageningen University and Research, Bornse Weilanden 9, 6708 WG Wageningen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoppenbrouwers</LastName><ForeName>Tamara</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Food and Biobased Research, Wageningen University and Research, Bornse Weilanden 9, 6708 WG Wageningen, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Food Quality and Design, Wageningen University and Research, Bornse Weilanden 9, 6708 WG Wageningen, The Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Nutrients</MedlineTA><NlmUniqueID>101521595</NlmUniqueID><ISSNLinking>2072-6643</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017127">Glycation End Products, Advanced</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000067759">Receptor for Advanced Glycation End Products</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001812" MajorTopicYN="N">Blood-Brain Barrier</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004032" MajorTopicYN="N">Diet</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017127" MajorTopicYN="N">Glycation End Products, Advanced</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017628" MajorTopicYN="N">Microglia</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009000" MajorTopicYN="N">Monocytes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009103" MajorTopicYN="N">Multiple Sclerosis</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="N">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000090862" MajorTopicYN="N">Neuroinflammatory Diseases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000067759" MajorTopicYN="N">Receptor for Advanced Glycation End Products</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AGEs</Keyword><Keyword MajorTopicYN="N">advanced glycation end products</Keyword><Keyword MajorTopicYN="N">blood&#x2013;brain barrier</Keyword><Keyword MajorTopicYN="N">in vitro models</Keyword><Keyword MajorTopicYN="N">inflammation</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword><Keyword MajorTopicYN="N">neuroinflammation</Keyword><Keyword MajorTopicYN="N">neuro&#x2013;immune axis</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>1</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>1</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>21</Day><Hour>1</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35057544</ArticleId><ArticleId IdType="pmc">PMC8777776</ArticleId><ArticleId IdType="doi">10.3390/nu14020363</ArticleId><ArticleId IdType="pii">nu14020363</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Maillard L.C. Action des acides amines sur les sucres; formation des melanoidines par voie methodique. Comptes R. Acad. Sci. Paris. 1912;154:66&#x2013;68.</Citation></Reference><Reference><Citation>Hodge J.E. Dehydrated Foods, Chemistry of Browning Reactions in Model Systems. J. Agric. Food Chem. 1953;1:928&#x2013;943. doi: 10.1021/jf60015a004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jf60015a004</ArticleId></ArticleIdList></Reference><Reference><Citation>Delgado-Andrade C., Fogliano V. Dietary Advanced Glycosylation End-Products (dAGEs) and Melanoidins Formed through the Maillard Reaction: Physiological Consequences of their Intake. Annu. Rev. Food Sci. Technol. 2018;9:271&#x2013;291. doi: 10.1146/annurev-food-030117-012441.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-food-030117-012441</ArticleId><ArticleId IdType="pubmed">29350563</ArticleId></ArticleIdList></Reference><Reference><Citation>Thornalley P.J. Dicarbonyl Intermediates in the Maillard Reaction. Ann. N. Y. Acad. Sci. 2005;1043:111&#x2013;117. doi: 10.1196/annals.1333.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1196/annals.1333.014</ArticleId><ArticleId IdType="pubmed">16037229</ArticleId></ArticleIdList></Reference><Reference><Citation>Tessier F.J. The Maillard reaction in the human body. The main discoveries and factors that affect glycation. Pathol. Biol. 2010;58:214&#x2013;219. doi: 10.1016/j.patbio.2009.09.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.patbio.2009.09.014</ArticleId><ArticleId IdType="pubmed">19896783</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Nguyen C. Toxicity of the AGEs generated from the Maillard reaction: On the relationship of food-AGEs and biological-AGEs. Mol. Nutr. Food Res. 2006;50:1140&#x2013;1149. doi: 10.1002/mnfr.200600144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mnfr.200600144</ArticleId><ArticleId IdType="pubmed">17131455</ArticleId></ArticleIdList></Reference><Reference><Citation>Vlassara H., Uribarri J. Advanced glycation end products (AGE) and diabetes: Cause, effect, or both? Curr. Diab. Rep. 2014;14:453. doi: 10.1007/s11892-013-0453-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11892-013-0453-1</ArticleId><ArticleId IdType="pmc">PMC3903318</ArticleId><ArticleId IdType="pubmed">24292971</ArticleId></ArticleIdList></Reference><Reference><Citation>Starowicz M., Zieli&#x144;ski H. How Maillard Reaction Influences Sensorial Properties (Color, Flavor and Texture) of Food Products? Food Rev. Int. 2019;35:707&#x2013;725. doi: 10.1080/87559129.2019.1600538.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/87559129.2019.1600538</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahbar S., Blumenfeld O., Ranney H.M. Studies of an unusual hemoglobin in patients with diabetes mellitus. Biochem. Biophys. Res. Commun. 1969;36:838&#x2013;843. doi: 10.1016/0006-291X(69)90685-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0006-291X(69)90685-8</ArticleId><ArticleId IdType="pubmed">5808299</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunkel H.G., Wallenius G. New hemoglobin in normal adult blood. Science. 1955;122:288. doi: 10.1126/science.122.3163.288.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.122.3163.288</ArticleId><ArticleId IdType="pubmed">13246634</ArticleId></ArticleIdList></Reference><Reference><Citation>Yatscoff R.W., Tevaarwerk G.J., MacDonald J.C. Quantification of nonenzymically glycated albumin and total serum protein by affinity chromatography. Clin. Chem. 1984;30:446&#x2013;449. doi: 10.1093/clinchem/30.3.446.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clinchem/30.3.446</ArticleId><ArticleId IdType="pubmed">6697494</ArticleId></ArticleIdList></Reference><Reference><Citation>Roth M. &#x201c;Glycated hemoglobin,&#x201d; not &#x201c;glycosylated&#x201d; or &#x201c;glucosylated&#x201d;. Clin. Chem. 1983;29:1991. doi: 10.1093/clinchem/29.11.1991.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clinchem/29.11.1991</ArticleId><ArticleId IdType="pubmed">6627645</ArticleId></ArticleIdList></Reference><Reference><Citation>Poulsen M.W., Hedegaard R.V., Andersen J.M., de Courten B., B&#xfc;gel S., Nielsen J., Skibsted L.H., Dragsted L.O. Advanced glycation endproducts in food and their effects on health. Food Chem. Toxicol. Int. J. Publ. Br. Ind. Biol. Res. Assoc. 2013;60:10&#x2013;37. doi: 10.1016/j.fct.2013.06.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fct.2013.06.052</ArticleId><ArticleId IdType="pubmed">23867544</ArticleId></ArticleIdList></Reference><Reference><Citation>Semba R.D., Nicklett E.J., Ferrucci L. Does accumulation of advanced glycation end products contribute to the aging phenotype? J. Gerontol. A Biol. Sci. Med. Sci. 2010;65:963&#x2013;975. doi: 10.1093/gerona/glq074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gerona/glq074</ArticleId><ArticleId IdType="pmc">PMC2920582</ArticleId><ArticleId IdType="pubmed">20478906</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulrich P., Cerami A. Protein glycation, diabetes, and aging. Recent Prog. Horm. Res. 2001;56:1&#x2013;21. doi: 10.1210/rp.56.1.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/rp.56.1.1</ArticleId><ArticleId IdType="pubmed">11237208</ArticleId></ArticleIdList></Reference><Reference><Citation>Monnier V.M., Cerami A. Nonenzymatic browning in vivo: Possible process for aging of long-lived proteins. Science. 1981;211:491&#x2013;493. doi: 10.1126/science.6779377.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.6779377</ArticleId><ArticleId IdType="pubmed">6779377</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheijen J.L.J.M., Clevers E., Engelen L., Dagnelie P.C., Brouns F., Stehouwer C.D.A., Schalkwijk C.G. Analysis of advanced glycation endproducts in selected food items by ultra-performance liquid chromatography tandem mass spectrometry: Presentation of a dietary AGE database. Food Chem. 2016;190:1145&#x2013;1150. doi: 10.1016/j.foodchem.2015.06.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.foodchem.2015.06.049</ArticleId><ArticleId IdType="pubmed">26213088</ArticleId></ArticleIdList></Reference><Reference><Citation>Degen J., Hellwig M., Henle T. 1,2-Dicarbonyl Compounds in Commonly Consumed Foods. J. Agric. Food Chem. 2012;60:7071&#x2013;7079. doi: 10.1021/jf301306g.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jf301306g</ArticleId><ArticleId IdType="pubmed">22724891</ArticleId></ArticleIdList></Reference><Reference><Citation>Uribarri J., Woodruff S., Goodman S., Cai W., Chen X., Pyzik R., Yong A., Striker G.E., Vlassara H. Advanced glycation end products in foods and a practical guide to their reduction in the diet. J. Am. Diet. Assoc. 2010;110:911&#x2013;916.e12. doi: 10.1016/j.jada.2010.03.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jada.2010.03.018</ArticleId><ArticleId IdType="pmc">PMC3704564</ArticleId><ArticleId IdType="pubmed">20497781</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramasamy R., Vannucci S.J., Yan S.S.D., Herold K., Yan S.F., Schmidt A.M. Advanced glycation end products and RAGE: A common thread in aging, diabetes, neurodegeneration, and inflammation. Glycobiology. 2005;15:16R&#x2013;28R. doi: 10.1093/glycob/cwi053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/glycob/cwi053</ArticleId><ArticleId IdType="pubmed">15764591</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed N., Battah S., Karachalias N., Babaei-Jadidi R., Hor&#xe1;nyi M., Bar&#xf3;ti K., Hollan S., Thornalley P.J. Increased formation of methylglyoxal and protein glycation, oxidation and nitrosation in triosephosphate isomerase deficiency. Biochim. Biophys. Acta - Mol. Basis Dis. 2003;1639:121&#x2013;132. doi: 10.1016/j.bbadis.2003.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2003.08.002</ArticleId><ArticleId IdType="pubmed">14559119</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillips S.A., Thornalley P.J. The formation of methylglyoxal from triose phosphates. Eur. J. Biochem. 1993;212:101&#x2013;105. doi: 10.1111/j.1432-1033.1993.tb17638.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1432-1033.1993.tb17638.x</ArticleId><ArticleId IdType="pubmed">8444148</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu G., Jousilahti P., Bidel S., Antikainen R., Tuomilehto J. Type 2 diabetes and the risk of Parkinson&#x2019;s disease. Diabetes Care. 2007;30:842&#x2013;847. doi: 10.2337/dc06-2011.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc06-2011</ArticleId><ArticleId IdType="pubmed">17251276</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q., Wang Y., Fu L. Dietary advanced glycation end-products: Perspectives linking food processing with health implications. Compr. Rev. Food Sci. Food Saf. 2020;19:2559&#x2013;2587. doi: 10.1111/1541-4337.12593.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1541-4337.12593</ArticleId><ArticleId IdType="pubmed">33336972</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheijen J.L.J.M., Hanssen N.M.J., van Greevenbroek M.M., Van der Kallen C.J., Feskens E.J.M., Stehouwer C.D.A., Schalkwijk C.G. Dietary intake of advanced glycation endproducts is associated with higher levels of advanced glycation endproducts in plasma and urine: The CODAM study. Clin. Nutr. 2018;37:919&#x2013;925. doi: 10.1016/j.clnu.2017.03.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clnu.2017.03.019</ArticleId><ArticleId IdType="pubmed">29381139</ArticleId></ArticleIdList></Reference><Reference><Citation>Tessier F.J., Niquet-L&#xe9;ridon C., Jacolot P., Jouquand C., Genin M., Schmidt A.-M., Grossin N., Boulanger E. Quantitative assessment of organ distribution of dietary protein-bound 13C-labeled N&#x25b;-carboxymethyllysine after a chronic oral exposure in mice. Mol. Nutr. Food Res. 2016;60:2446&#x2013;2456. doi: 10.1002/mnfr.201600140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mnfr.201600140</ArticleId><ArticleId IdType="pubmed">27393741</ArticleId></ArticleIdList></Reference><Reference><Citation>Roncero-Ramos I., Niquet-L&#xe9;ridon C., Strauch C., Monnier V.M., Tessier F.J., Navarro M.P., Delgado-Andrade C. An advanced glycation end product (AGE)-rich diet promotes N&#x3b5;-carboxymethyl-lysine accumulation in the cardiac tissue and tendons of rats. J. Agric. Food Chem. 2014;62:6001&#x2013;6006. doi: 10.1021/jf501005n.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jf501005n</ArticleId><ArticleId IdType="pubmed">24892987</ArticleId></ArticleIdList></Reference><Reference><Citation>Koschinsky T., He C.J., Mitsuhashi T., Bucala R., Liu C., Buenting C., Heitmann K., Vlassara H. Orally absorbed reactive glycation products (glycotoxins): An environmental risk factor in diabetic nephropathy. Proc. Natl. Acad. Sci. USA. 1997;94:6474&#x2013;6479. doi: 10.1073/pnas.94.12.6474.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.94.12.6474</ArticleId><ArticleId IdType="pmc">PMC21074</ArticleId><ArticleId IdType="pubmed">9177242</ArticleId></ArticleIdList></Reference><Reference><Citation>He C., Sabol J., Mitsuhashi T., Vlassara H. Dietary glycotoxins: Inhibition of reactive products by aminoguanidine facilitates renal clearance and reduces tissue sequestration. Diabetes. 1999;48:1308&#x2013;1315. doi: 10.2337/diabetes.48.6.1308.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diabetes.48.6.1308</ArticleId><ArticleId IdType="pubmed">10342821</ArticleId></ArticleIdList></Reference><Reference><Citation>Aragon&#xe8;s G., Rowan S., Francisco S.G., Whitcomb E.A., Yang W., Perini-Villanueva G., Schalkwijk C.G., Taylor A., Bejarano E. The Glyoxalase System in Age-Related Diseases: Nutritional Intervention as Anti-Ageing Strategy. Cells. 2021;10:1852. doi: 10.3390/cells10081852.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10081852</ArticleId><ArticleId IdType="pmc">PMC8393707</ArticleId><ArticleId IdType="pubmed">34440621</ArticleId></ArticleIdList></Reference><Reference><Citation>Jack M., Wright D. Role of advanced glycation endproducts and glyoxalase I in diabetic peripheral sensory neuropathy. Transl. Res. 2012;159:355&#x2013;365. doi: 10.1016/j.trsl.2011.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trsl.2011.12.004</ArticleId><ArticleId IdType="pmc">PMC3329218</ArticleId><ArticleId IdType="pubmed">22500508</ArticleId></ArticleIdList></Reference><Reference><Citation>Trellu S., Courties A., Jaisson S., Gorisse L., Gillery P., Kerdine-R&#xf6;mer S., Vaamonde-Garcia C., Houard X., Ekhirch F.-P., Sautet A., et al. Impairment of glyoxalase-1, an advanced glycation end-product detoxifying enzyme, induced by inflammation in age-related osteoarthritis. Arthritis Res. Ther. 2019;21:18. doi: 10.1186/s13075-018-1801-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-018-1801-y</ArticleId><ArticleId IdType="pmc">PMC6330409</ArticleId><ArticleId IdType="pubmed">30635030</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue M., Rabbani N., Thornalley P.J. Glyoxalase in ageing. Semin. Cell Dev. Biol. 2011;22:293&#x2013;301. doi: 10.1016/j.semcdb.2011.02.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcdb.2011.02.013</ArticleId><ArticleId IdType="pubmed">21320620</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhla B., Boeck K., L&#xfc;th H.-J., Schmidt A., Weigle B., Schmitz M., Ogunlade V., M&#xfc;nch G., Arendt T. Age-dependent changes of glyoxalase I expression in human brain. Neurobiol. Aging. 2006;27:815&#x2013;822. doi: 10.1016/j.neurobiolaging.2005.04.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2005.04.006</ArticleId><ArticleId IdType="pubmed">15950319</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen F., Wollmer M.A., Hoerndli F., M&#xfc;nch G., Kuhla B., Rogaev E.I., Tsolaki M., Papassotiropoulos A., G&#xf6;tz J. Role for glyoxalase I in Alzheimer&#x2019;s disease. Proc. Natl. Acad. Sci. USA. 2004;101:7687&#x2013;7692. doi: 10.1073/pnas.0402338101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0402338101</ArticleId><ArticleId IdType="pmc">PMC419667</ArticleId><ArticleId IdType="pubmed">15128939</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xfc;th H.-J., Ogunlade V., Kuhla B., Kientsch-Engel R., Stahl P., Webster J., Arendt T., M&#xfc;nch G. Age- and stage-dependent accumulation of advanced glycation end products in intracellular deposits in normal and Alzheimer&#x2019;s disease brains. Cereb. Cortex. 2005;15:211&#x2013;220. doi: 10.1093/cercor/bhh123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cercor/bhh123</ArticleId><ArticleId IdType="pubmed">15238435</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;nch G., Thome J., Foley P., Schinzel R., Riederer P. Advanced glycation endproducts in ageing and Alzheimer&#x2019;s disease. Brain Res. Rev. 1997;23:134&#x2013;143. doi: 10.1016/S0165-0173(96)00016-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0165-0173(96)00016-1</ArticleId><ArticleId IdType="pubmed">9063589</ArticleId></ArticleIdList></Reference><Reference><Citation>Vitek M.P., Bhattacharya K., Glendening J.M., Stopa E., Vlassara H., Bucala R., Manogue K., Cerami A. Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proc. Natl. Acad. Sci. USA. 1994;91:4766&#x2013;4770. doi: 10.1073/pnas.91.11.4766.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.91.11.4766</ArticleId><ArticleId IdType="pmc">PMC43869</ArticleId><ArticleId IdType="pubmed">8197133</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;nch G., L&#xfc;th H.J., Wong A., Arendt T., Hirsch E., Ravid R., Riederer P. Crosslinking of alpha-synuclein by advanced glycation endproducts&#x2014;An early pathophysiological step in Lewy body formation? J. Chem. Neuroanat. 2000;20:253&#x2013;257. doi: 10.1016/S0891-0618(00)00096-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0891-0618(00)00096-X</ArticleId><ArticleId IdType="pubmed">11207423</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki N., Fukatsu R., Tsuzuki K., Hayashi Y., Yoshida T., Fujii N., Koike T., Wakayama I., Yanagihara R., Garruto R., et al. Advanced glycation end products in Alzheimer&#x2019;s disease and other neurodegenerative diseases. Am. J. Pathol. 1998;153:1149&#x2013;1155. doi: 10.1016/S0002-9440(10)65659-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9440(10)65659-3</ArticleId><ArticleId IdType="pmc">PMC1853056</ArticleId><ArticleId IdType="pubmed">9777946</ArticleId></ArticleIdList></Reference><Reference><Citation>Choei H., Sasaki N., Takeuchi M., Yoshida T., Ukai W., Yamagishi S., Kikuchi S., Saito T. Glyceraldehyde-derived advanced glycation end products in Alzheimer&#x2019;s disease. Acta Neuropathol. 2004;108:189&#x2013;193. doi: 10.1007/s00401-004-0871-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-004-0871-x</ArticleId><ArticleId IdType="pubmed">15221334</ArticleId></ArticleIdList></Reference><Reference><Citation>Shuvaev V.V., Laffont I., Serot J.-M., Fujii J., Taniguchi N., Siest G. Increased protein glycation in cerebrospinal fluid of Alzheimer&#x2019;s disease. Neurobiol. Aging. 2001;22:397&#x2013;402. doi: 10.1016/S0197-4580(00)00253-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0197-4580(00)00253-0</ArticleId><ArticleId IdType="pubmed">11378244</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Liu D., Sun L., Lu Y., Zhang Z. Advanced glycation end products and neurodegenerative diseases: Mechanisms and perspective. J. Neurol. Sci. 2012;317:1&#x2013;5. doi: 10.1016/j.jns.2012.02.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2012.02.018</ArticleId><ArticleId IdType="pubmed">22410257</ArticleId></ArticleIdList></Reference><Reference><Citation>Meli M., Perier C., Ferron C., Parssegny F., Denis C., Gonthier R., Laurent B., Reynaud E., Frey J., Chamson A. Serum pentosidine as an indicator of Alzheimer&#x2019;s disease. J. Alzheimers Dis. 2002;4:93&#x2013;96. doi: 10.3233/JAD-2002-4203.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-2002-4203</ArticleId><ArticleId IdType="pubmed">12214132</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith M.A., Taneda S., Richey P.L., Miyata S., Yan S.D., Stern D., Sayre L.M., Monnier V.M., Perry G. Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc. Natl. Acad. Sci. USA. 1994;91:5710&#x2013;5714. doi: 10.1073/pnas.91.12.5710.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.91.12.5710</ArticleId><ArticleId IdType="pmc">PMC44066</ArticleId><ArticleId IdType="pubmed">8202552</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed N., Ahmed U., Thornalley P.J., Hager K., Fleischer G., M&#xfc;nch G. Protein glycation, oxidation and nitration adduct residues and free adducts of cerebrospinal fluid in Alzheimer&#x2019;s disease and link to cognitive impairment. J. Neurochem. 2005;92:255&#x2013;263. doi: 10.1111/j.1471-4159.2004.02864.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2004.02864.x</ArticleId><ArticleId IdType="pubmed">15663474</ArticleId></ArticleIdList></Reference><Reference><Citation>Wetzels S., Vanmierlo T., Scheijen J.L.J.M., van Horssen J., Amor S., Somers V., Schalkwijk C.G., Hendriks J.J.A., Wouters K. Methylglyoxal-Derived Advanced Glycation Endproducts Accumulate in Multiple Sclerosis Lesions. Front. Immunol. 2019;10:855. doi: 10.3389/fimmu.2019.00855.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.00855</ArticleId><ArticleId IdType="pmc">PMC6491451</ArticleId><ArticleId IdType="pubmed">31068938</ArticleId></ArticleIdList></Reference><Reference><Citation>Castellani R., Smith M.A., Richey G.L., Perry G. Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease. Brain Res. 1996;737:195&#x2013;200. doi: 10.1016/0006-8993(96)00729-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0006-8993(96)00729-9</ArticleId><ArticleId IdType="pubmed">8930366</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaikh S., Nicholson L.F.B. Advanced glycation end products induce in vitro cross-linking of &#x3b1;-synuclein and accelerate the process of intracellular inclusion body formation. J. Neurosci. Res. 2008;86:2071&#x2013;2082. doi: 10.1002/jnr.21644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.21644</ArticleId><ArticleId IdType="pubmed">18335520</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;nch G., Mayer S., Michaelis J., Hipkiss A.R., Riederer P., M&#xfc;ller R., Neumann A., Schinzel R., Cunningham A.M. Influence of advanced glycation end-products and AGE-inhibitors on nucleation-dependent polymerization of &#x3b2;-amyloid peptide. Biochim. Biophys. Acta -Mol. Basis Dis. 1997;1360:17&#x2013;29. doi: 10.1016/S0925-4439(96)00062-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0925-4439(96)00062-2</ArticleId><ArticleId IdType="pubmed">9061036</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko S.-Y., Lin Y.-S., Lin Y.-S., Chang S.-S. Advanced glycation end products enhance amyloid precursor protein expression by inducing reactive oxygen species. Free Radic. Biol. Med. 2010;49:474&#x2013;480. doi: 10.1016/j.freeradbiomed.2010.05.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2010.05.005</ArticleId><ArticleId IdType="pubmed">20471471</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbott N.J., Patabendige A.A.K., Dolman D.E.M., Yusof S.R., Begley D.J. Structure and function of the blood&#x2013;brain barrier. Neurobiol. Dis. 2010;37:13&#x2013;25. doi: 10.1016/j.nbd.2009.07.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2009.07.030</ArticleId><ArticleId IdType="pubmed">19664713</ArticleId></ArticleIdList></Reference><Reference><Citation>Luissint A.-C., Artus C., Glacial F., Ganeshamoorthy K., Couraud P.-O. Tight junctions at the blood brain barrier: Physiological architecture and disease-associated dysregulation. Fluids Barriers CNS. 2012;9:23. doi: 10.1186/2045-8118-9-23.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2045-8118-9-23</ArticleId><ArticleId IdType="pmc">PMC3542074</ArticleId><ArticleId IdType="pubmed">23140302</ArticleId></ArticleIdList></Reference><Reference><Citation>Oller-Salvia B., S&#xe1;nchez-Navarro M., Giralt E., Teixid&#xf3; M. Blood-brain barrier shuttle peptides: An emerging paradigm for brain delivery. Chem. Soc. Rev. 2016;45:4690&#x2013;4707. doi: 10.1039/C6CS00076B.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C6CS00076B</ArticleId><ArticleId IdType="pubmed">27188322</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweeney M.D., Sagare A.P., Zlokovic B.V. Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat. Rev. Neurol. 2018;14:133&#x2013;150. doi: 10.1038/nrneurol.2017.188.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2017.188</ArticleId><ArticleId IdType="pmc">PMC5829048</ArticleId><ArticleId IdType="pubmed">29377008</ArticleId></ArticleIdList></Reference><Reference><Citation>Rom S., Heldt N.A., Gajghate S., Seliga A., Reichenbach N.L., Persidsky Y. Hyperglycemia and advanced glycation end products disrupt BBB and promote occludin and claudin-5 protein secretion on extracellular microvesicles. Sci. Rep. 2020;10:7274. doi: 10.1038/s41598-020-64349-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-64349-x</ArticleId><ArticleId IdType="pmc">PMC7190636</ArticleId><ArticleId IdType="pubmed">32350344</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahriyary L., Riazi G., Lornejad M.R., Ghezlou M., Bigdeli B., Delavari B., Mamashli F., Abbasi S., Davoodi J., Saboury A.A. Effect of glycated insulin on the blood-brain barrier permeability: An in vitro study. Arch. Biochem. Biophys. 2018;647:54&#x2013;66. doi: 10.1016/j.abb.2018.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.abb.2018.02.004</ArticleId><ArticleId IdType="pubmed">29444458</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu F., Sano Y., Tominaga O., Maeda T., Abe M.A., Kanda T. Advanced glycation end-products disrupt the blood-brain barrier by stimulating the release of transforming growth factor-&#x3b2; by pericytes and vascular endothelial growth factor and matrix metalloproteinase-2 by endothelial cells in vitro. Neurobiol. Aging. 2013;34:1902&#x2013;1912. doi: 10.1016/j.neurobiolaging.2013.01.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2013.01.012</ArticleId><ArticleId IdType="pubmed">23428182</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobi A., Rosanaly S., Devin A., Baret P., Meilhac O., Harry G.J., D&#x2019;Hellencourt C.L., Rondeau P. Advanced glycation end-products disrupt brain microvascular endothelial cell barrier: The role of mitochondria and oxidative stress. Microvasc. Res. 2021;133:104098. doi: 10.1016/j.mvr.2020.104098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mvr.2020.104098</ArticleId><ArticleId IdType="pmc">PMC8782206</ArticleId><ArticleId IdType="pubmed">33075405</ArticleId></ArticleIdList></Reference><Reference><Citation>Mittelbronn M., Dietz K., Schluesener H.J., Meyermann R. Local distribution of microglia in the normal adult human central nervous system differs by up to one order of magnitude. Acta Neuropathol. 2001;101:249&#x2013;255. doi: 10.1007/s004010000284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004010000284</ArticleId><ArticleId IdType="pubmed">11307625</ArticleId></ArticleIdList></Reference><Reference><Citation>J&#xe4;kel S., Dimou L. Glial Cells and Their Function in the Adult Brain: A Journey through the History of Their Ablation. Front. Cell. Neurosci. 2017;11:24. doi: 10.3389/fncel.2017.00024.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2017.00024</ArticleId><ArticleId IdType="pmc">PMC5303749</ArticleId><ArticleId IdType="pubmed">28243193</ArticleId></ArticleIdList></Reference><Reference><Citation>Vezzani A., Viviani B. Neuromodulatory properties of inflammatory cytokines and their impact on neuronal excitability. Neuropharmacology. 2015;96:70&#x2013;82. doi: 10.1016/j.neuropharm.2014.10.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2014.10.027</ArticleId><ArticleId IdType="pubmed">25445483</ArticleId></ArticleIdList></Reference><Reference><Citation>Ransohoff R.M., Perry V.H. Microglial physiology: Unique stimuli, specialized responses. Annu. Rev. Immunol. 2009;27:119&#x2013;145. doi: 10.1146/annurev.immunol.021908.132528.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.immunol.021908.132528</ArticleId><ArticleId IdType="pubmed">19302036</ArticleId></ArticleIdList></Reference><Reference><Citation>Nimmerjahn A., Kirchhoff F., Helmchen F. Resting Microglial Cells Are Highly Dynamic Surveillants of Brain Parenchyma In Vivo. Science. 2005;308:1314&#x2013;1318. doi: 10.1126/science.1110647.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1110647</ArticleId><ArticleId IdType="pubmed">15831717</ArticleId></ArticleIdList></Reference><Reference><Citation>Graeber M.B., Li W., Rodriguez M.L. Role of microglia in CNS inflammation. FEBS Lett. 2011;585:3798&#x2013;3805. doi: 10.1016/j.febslet.2011.08.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2011.08.033</ArticleId><ArticleId IdType="pubmed">21889505</ArticleId></ArticleIdList></Reference><Reference><Citation>Timmerman R., Burm S.M., Bajramovic J.J. An overview of in vitro methods to study microglia. Front. Cell. Neurosci. 2018;12:242. doi: 10.3389/fncel.2018.00242.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2018.00242</ArticleId><ArticleId IdType="pmc">PMC6087748</ArticleId><ArticleId IdType="pubmed">30127723</ArticleId></ArticleIdList></Reference><Reference><Citation>Olah M., Biber K., Vinet J., Wgm Boddeke H. Microglia Phenotype Diversity. CNS Neurol. Disord. -Drug Targets. 2011;10:108&#x2013;118. doi: 10.2174/187152711794488575.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/187152711794488575</ArticleId><ArticleId IdType="pubmed">21143141</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerschensteiner M., Meinl E., Hohlfeld R. Neuro-immune crosstalk in CNS diseases. Neuroscience. 2009;158:1122&#x2013;1132. doi: 10.1016/j.neuroscience.2008.09.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2008.09.009</ArticleId><ArticleId IdType="pubmed">18848864</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian L., Ma L., Kaarela T., Li Z. Neuroimmune crosstalk in the central nervous system and its significance for neurological diseases. J. Neuroinflamm. 2012;9:155. doi: 10.1186/1742-2094-9-155.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-9-155</ArticleId><ArticleId IdType="pmc">PMC3410819</ArticleId><ArticleId IdType="pubmed">22747919</ArticleId></ArticleIdList></Reference><Reference><Citation>Skaper S.D., Giusti P., Facci L. Microglia and mast cells: Two tracks on the road to neuroinflammation. FASEB J. 2012;26:3103&#x2013;3117. doi: 10.1096/fj.11-197194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.11-197194</ArticleId><ArticleId IdType="pubmed">22516295</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabogal-Gu&#xe1;queta A.M., Marmolejo-Garza A., de P&#xe1;dua V.P., Eggen B., Boddeke E., Dolga A.M. Microglia alterations in neurodegenerative diseases and their modeling with human induced pluripotent stem cell and other platforms. Prog. Neurobiol. 2020;190:101805. doi: 10.1016/j.pneurobio.2020.101805.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2020.101805</ArticleId><ArticleId IdType="pubmed">32335273</ArticleId></ArticleIdList></Reference><Reference><Citation>Dheen S.T., Kaur C., Ling E.-A. Microglial activation and its implications in the brain diseases. Curr. Med. Chem. 2007;14:1189&#x2013;1197. doi: 10.2174/092986707780597961.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/092986707780597961</ArticleId><ArticleId IdType="pubmed">17504139</ArticleId></ArticleIdList></Reference><Reference><Citation>Amor S., Puentes F., Baker D., Van Der Valk P. Inflammation in neurodegenerative diseases. Immunology. 2010;129:154&#x2013;169. doi: 10.1111/j.1365-2567.2009.03225.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2567.2009.03225.x</ArticleId><ArticleId IdType="pmc">PMC2814458</ArticleId><ArticleId IdType="pubmed">20561356</ArticleId></ArticleIdList></Reference><Reference><Citation>Andreasson K.I., Bachstetter A.D., Colonna M., Ginhoux F., Holmes C., Lamb B., Landreth G., Lee D.C., Low D., Lynch M.A., et al. Targeting innate immunity for neurodegenerative disorders of the central nervous system. J. Neurochem. 2016;138:653&#x2013;693. doi: 10.1111/jnc.13667.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.13667</ArticleId><ArticleId IdType="pmc">PMC5433264</ArticleId><ArticleId IdType="pubmed">27248001</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeda A., Yasuda T., Miyata T., Goto Y., Wakai M., Watanabe M., Yasuda Y., Horie K., Inagaki T., Doyu M. Advanced glycation end products co-localized with astrocytes and microglial cells in Alzheimer&#x2019;s disease brain. Acta Neuropathol. 1998;95:555&#x2013;558. doi: 10.1007/s004010050839.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004010050839</ArticleId><ArticleId IdType="pubmed">9650745</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickson D.W., Sinicropi S., Yen S.-H., Ko L.-W., Mattiace L.A., Bucala R., Vlassara H. Glycation and microglial reaction in lesions of Alzheimer&#x2019;s disease. Neurobiol. Aging. 1996;17:733&#x2013;743. doi: 10.1016/0197-4580(96)00116-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0197-4580(96)00116-9</ArticleId><ArticleId IdType="pubmed">8892346</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie I.R.A. Activated microglia in dementia with Lewy bodies. Neurology. 2000;55:132&#x2013;134. doi: 10.1212/WNL.55.1.132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.55.1.132</ArticleId><ArticleId IdType="pubmed">10891923</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall E.D., Oostveen J.A., Gurney M.E. Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS. Glia. 1998;23:249&#x2013;256. doi: 10.1002/(SICI)1098-1136(199807)23:3&lt;249::AID-GLIA7&gt;3.0.CO;2-#.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1098-1136(199807)23:3&lt;249::AID-GLIA7&gt;3.0.CO;2-#</ArticleId><ArticleId IdType="pubmed">9633809</ArticleId></ArticleIdList></Reference><Reference><Citation>McGeer P.L., Kawamata T., Walker D.G., Akiyama H., Tooyama I., McGeer E.G. Microglia in degenerative neurological disease. Glia. 1993;7:84&#x2013;92. doi: 10.1002/glia.440070114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.440070114</ArticleId><ArticleId IdType="pubmed">8423066</ArticleId></ArticleIdList></Reference><Reference><Citation>McGeer P.L., Itagaki S., Boyes B.E., McGeer E.G. Reactive microglia are positive for HLA-DR in the: Substantia nigra of Parkinson&#x2019;s and Alzheimer&#x2019;s disease brains. Neurology. 1988;38:1285. doi: 10.1212/WNL.38.8.1285.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.38.8.1285</ArticleId><ArticleId IdType="pubmed">3399080</ArticleId></ArticleIdList></Reference><Reference><Citation>Schumacher U., Kretzschmar H., Pf&#xfc;ller U. Staining of cerebral amyloid plaque glycoproteins in patients with Alzheimer&#x2019;s disease with the microglia-specific lectin from mistletoe. Acta Neuropathol. 1994;87:422&#x2013;424. doi: 10.1007/BF00313612.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00313612</ArticleId><ArticleId IdType="pubmed">7517091</ArticleId></ArticleIdList></Reference><Reference><Citation>Edison P., Archer H.A., Gerhard A., Hinz R., Pavese N., Turkheimer F.E., Hammers A., Tai Y.F., Fox N., Kennedy A., et al. Microglia, amyloid, and cognition in Alzheimer&#x2019;s disease: An [11C](R)PK11195-PET and [11C]PIB-PET study. Neurobiol. Dis. 2008;32:412&#x2013;419. doi: 10.1016/j.nbd.2008.08.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2008.08.001</ArticleId><ArticleId IdType="pubmed">18786637</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanisch U. Microglia as a source and target of cytokines. Glia. 2002;40:140&#x2013;155. doi: 10.1002/glia.10161.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.10161</ArticleId><ArticleId IdType="pubmed">12379902</ArticleId></ArticleIdList></Reference><Reference><Citation>Shigemoto-Mogami Y., Hoshikawa K., Sato K. Activated microglia disrupt the blood-brain barrier and induce chemokines and cytokines in a rat in vitro model. Front. Cell. Neurosci. 2018;12:494. doi: 10.3389/fncel.2018.00494.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2018.00494</ArticleId><ArticleId IdType="pmc">PMC6300509</ArticleId><ArticleId IdType="pubmed">30618641</ArticleId></ArticleIdList></Reference><Reference><Citation>Yenari M.A., Xu L., Tang X.N., Qiao Y., Giffard R.G. Microglia potentiate damage to blood-brain barrier constituents: Improvement by minocycline in vivo and in vitro. Stroke. 2006;37:1087&#x2013;1093. doi: 10.1161/01.STR.0000206281.77178.ac.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.STR.0000206281.77178.ac</ArticleId><ArticleId IdType="pubmed">16497985</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki R., Fujiwara Y., Saito M., Arakawa S., Shirakawa J.-I., Yamanaka M., Komohara Y., Marumo K., Nagai R. Intracellular Accumulation of Advanced Glycation End Products Induces Osteoblast Apoptosis Via Endoplasmic Reticulum Stress. J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res. 2020;35:1992&#x2013;2003. doi: 10.1002/jbmr.4053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbmr.4053</ArticleId><ArticleId IdType="pubmed">32427355</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J., Sun Z., Jin M., Tu Y., Wang S., Yang X., Chen Q., Zhang X., Han Y., Pi R. Inhibition of AGEs/RAGE/Rho/ROCK pathway suppresses non-specific neuroinflammation by regulating BV2 microglial M1/M2 polarization through the NF-&#x3ba;B pathway. J. Neuroimmunol. 2017;305:108&#x2013;114. doi: 10.1016/j.jneuroim.2017.02.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2017.02.010</ArticleId><ArticleId IdType="pubmed">28284330</ArticleId></ArticleIdList></Reference><Reference><Citation>Singel K.L., Segal B.H. NOX2-dependent regulation of inflammation. Clin. Sci. 2016;130:479&#x2013;490. doi: 10.1042/CS20150660.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20150660</ArticleId><ArticleId IdType="pmc">PMC5513728</ArticleId><ArticleId IdType="pubmed">26888560</ArticleId></ArticleIdList></Reference><Reference><Citation>Subedi L., Lee J.H., Gaire B.P., Kim S.Y. Sulforaphane Inhibits MGO-AGE-Mediated Neuroinflammation by Suppressing NF-&#x3ba;B, MAPK, and AGE&#x2013;RAGE Signaling Pathways in Microglial Cells. Antioxidants. 2020;9:792. doi: 10.3390/antiox9090792.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox9090792</ArticleId><ArticleId IdType="pmc">PMC7554773</ArticleId><ArticleId IdType="pubmed">32859007</ArticleId></ArticleIdList></Reference><Reference><Citation>He F.Q., Qiu B.Y., Li T.K., Xie Q., Cui D.J., Huang X.L., Gan H.T. Tetrandrine suppresses amyloid-&#x3b2;-induced inflammatory cytokines by inhibiting NF-&#x3ba;B pathway in murine BV2 microglial cells. Int. Immunopharmacol. 2011;11:1220&#x2013;1225. doi: 10.1016/j.intimp.2011.03.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2011.03.023</ArticleId><ArticleId IdType="pubmed">21496499</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt A.M., Yan S.D., Yan S.F., Stern D.M. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J. Clin. Investig. 2001;108:949&#x2013;955. doi: 10.1172/JCI200114002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI200114002</ArticleId><ArticleId IdType="pmc">PMC200958</ArticleId><ArticleId IdType="pubmed">11581294</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin X., Yao T., Zhou Z., Zhu J., Zhang S., Hu W., Shen C. Advanced glycation end products enhance macrophages polarization into M1 phenotype through activating RAGE/NF-B Pathway. Biomed Res. Int. 2015;2015:732450. doi: 10.1155/2015/732450.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/732450</ArticleId><ArticleId IdType="pmc">PMC4465680</ArticleId><ArticleId IdType="pubmed">26114112</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang F., Wang Z., Zhang J.H., Tang J., Liu X., Tan L., Huang Q.Y., Feng H. Receptor for Advanced Glycation End-Product Antagonist Reduces Blood-Brain Barrier Damage after Intracerebral Hemorrhage. Stroke. 2015;46:1328&#x2013;1336. doi: 10.1161/STROKEAHA.114.008336.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.114.008336</ArticleId><ArticleId IdType="pubmed">25782468</ArticleId></ArticleIdList></Reference><Reference><Citation>Byun K., Yoo Y.C., Son M., Lee J., Jeong G.B., Park Y.M., Salekdeh G.H., Lee B. Advanced glycation end-products produced systemically and by macrophages: A common contributor to inflammation and degenerative diseases. Pharmacol. Ther. 2017;177:44&#x2013;55. doi: 10.1016/j.pharmthera.2017.02.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2017.02.030</ArticleId><ArticleId IdType="pubmed">28223234</ArticleId></ArticleIdList></Reference><Reference><Citation>Son M., Kang W.C., Oh S., Bayarsaikhan D., Ahn H., Lee J., Park H., Lee S., Choi J., Lee H.S. Advanced glycation end-product (AGE)-albumin from activated macrophage is critical in human mesenchymal stem cells survival and post-ischemic reperfusion injury. Sci. Rep. 2017;7:11593. doi: 10.1038/s41598-017-11773-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-11773-1</ArticleId><ArticleId IdType="pmc">PMC5599509</ArticleId><ArticleId IdType="pubmed">28912521</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahn S.M., Byun K., Cho K., Kim J.Y., Yoo J.S., Kim D., Paek S.H., Kim S.U., Simpson R.J., Lee B., et al. Human microglial cells synthesize albumin in brain. PLoS ONE. 2008;3:4&#x2013;9. doi: 10.1371/journal.pone.0002829.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0002829</ArticleId><ArticleId IdType="pmc">PMC2483733</ArticleId><ArticleId IdType="pubmed">18665237</ArticleId></ArticleIdList></Reference><Reference><Citation>Byun K., Bayarsaikhan E., Kim D., Kim C.Y., Mook-Jung I., Paek S.H., Kim S.U., Yamamoto T., Won M.H., Song B.J., et al. Induction of neuronal death by microglial AGE-albumin: Implications for Alzheimer&#x2019;s disease. PLoS ONE. 2012;7:e37917. doi: 10.1371/journal.pone.0037917.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0037917</ArticleId><ArticleId IdType="pmc">PMC3360664</ArticleId><ArticleId IdType="pubmed">22662249</ArticleId></ArticleIdList></Reference><Reference><Citation>Byun K., Bayarsaikhan E., Kim D., Son M., Hong J., Jeong G.-B., Paek S.H., Won M.-H., Lee B. Activated microglial cells synthesize and secrete AGE-albumin. Anat. Cell Biol. 2012;45:47&#x2013;52. doi: 10.5115/acb.2012.45.1.47.</Citation><ArticleIdList><ArticleId IdType="doi">10.5115/acb.2012.45.1.47</ArticleId><ArticleId IdType="pmc">PMC3328740</ArticleId><ArticleId IdType="pubmed">22536551</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;nch G., Gasic-Milenkovic J., Dukic-Stefanovic S., Kuhla B., Heinrich K., Riederer P., Huttunen H.J., Founds H., Sajithlal G. Microglial activation induces cell death, inhibits neurite outgrowth and causes neurite retraction of differentiated neuroblastoma cells. Exp. Brain Res. 2003;150:1&#x2013;8. doi: 10.1007/s00221-003-1389-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00221-003-1389-5</ArticleId><ArticleId IdType="pubmed">12698210</ArticleId></ArticleIdList></Reference><Reference><Citation>Koriyama Y., Furukawa A., Muramatsu M., Takino J., Takeuchi M. Glyceraldehyde caused Alzheimer&#x2019;s disease-like alterations in diagnostic marker levels in SH-SY5Y human neuroblastoma cells. Sci. Rep. 2015;5:13313. doi: 10.1038/srep13313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep13313</ArticleId><ArticleId IdType="pmc">PMC4548441</ArticleId><ArticleId IdType="pubmed">26304819</ArticleId></ArticleIdList></Reference><Reference><Citation>Stansley B., Post J., Hensley K. A comparative review of cell culture systems for the study of microglial biology in Alzheimer&#x2019;s disease. J. Neuroinflamm. 2012;9:115. doi: 10.1186/1742-2094-9-115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-9-115</ArticleId><ArticleId IdType="pmc">PMC3407712</ArticleId><ArticleId IdType="pubmed">22651808</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasi E., Barluzzi R., Bocchini V., Mazzolla R., Bistoni F. Immortalization of murine microglial cells by a v-raf/v-myc carrying retrovirus. J. Neuroimmunol. 1990;27:229&#x2013;237. doi: 10.1016/0165-5728(90)90073-V.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0165-5728(90)90073-V</ArticleId><ArticleId IdType="pubmed">2110186</ArticleId></ArticleIdList></Reference><Reference><Citation>MacLean M., Juranek J., Cuddapah S., L&#xf3;pez-D&#xed;ez R., Ruiz H.H., Hu J., Frye L., Li H., Gugger P.F., Schmidt A.M. Microglia RAGE exacerbates the progression of neurodegeneration within the SOD1G93A murine model of amyotrophic lateral sclerosis in a sex-dependent manner. J. Neuroinflamm. 2021;18:139. doi: 10.1186/s12974-021-02191-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-021-02191-2</ArticleId><ArticleId IdType="pmc">PMC8207569</ArticleId><ArticleId IdType="pubmed">34130712</ArticleId></ArticleIdList></Reference><Reference><Citation>Kopec K.K., Carroll R.T. Alzheimer&#x2019;s beta-amyloid peptide 1-42 induces a phagocytic response in murine microglia. J. Neurochem. 1998;71:2123&#x2013;2131. doi: 10.1046/j.1471-4159.1998.71052123.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.1998.71052123.x</ArticleId><ArticleId IdType="pubmed">9798938</ArticleId></ArticleIdList></Reference><Reference><Citation>Bignami A., Eng L.F., Dahl D., Uyeda C.T. Localization of the glial fibrillary acidic protein in astrocytes by immunofluorescence. Brain Res. 1972;43:429&#x2013;435. doi: 10.1016/0006-8993(72)90398-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0006-8993(72)90398-8</ArticleId><ArticleId IdType="pubmed">4559710</ArticleId></ArticleIdList></Reference><Reference><Citation>Horvath R.J., Nutile-McMenemy N., Alkaitis M.S., DeLeo J.A. Differential migration, LPS-induced cytokine, chemokine, and NO expression in immortalized BV-2 and HAPI cell lines and primary microglial cultures. J. Neurochem. 2008;107:557&#x2013;569. doi: 10.1111/j.1471-4159.2008.05633.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2008.05633.x</ArticleId><ArticleId IdType="pmc">PMC2581646</ArticleId><ArticleId IdType="pubmed">18717813</ArticleId></ArticleIdList></Reference><Reference><Citation>Henn A., Lund S., Hedtj&#xe4;rn M., Schrattenholz A., P&#xf6;rzgen P., Leist M. The suitability of BV2 cells as alternative model system for primary microglia cultures or for animal experiments examining brain inflammation. ALTEX. 2009;26:83&#x2013;94. doi: 10.14573/altex.2009.2.83.</Citation><ArticleIdList><ArticleId IdType="doi">10.14573/altex.2009.2.83</ArticleId><ArticleId IdType="pubmed">19565166</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding B., Lin C., Liu Q., He Y., Ruganzu J.B., Jin H., Peng X., Ji S., Ma Y., Yang W. Tanshinone IIA attenuates neuroinflammation via inhibiting RAGE/NF-&#x3ba;B signaling pathway in vivo and in vitro. J. Neuroinflamm. 2020;17:302. doi: 10.1186/s12974-020-01981-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-020-01981-4</ArticleId><ArticleId IdType="pmc">PMC7559789</ArticleId><ArticleId IdType="pubmed">33054814</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H., Yu J.S., Zhang D.D., Yang Y.Q., Huang L.T., Yu Z., Chen R.D., Yang H.K., Hang C.H. Inhibition of the Receptor for Advanced Glycation End-Products (RAGE) Attenuates Neuroinflammation While Sensitizing Cortical Neurons Towards Death in Experimental Subarachnoid Hemorrhage. Mol. Neurobiol. 2017;54:755&#x2013;767. doi: 10.1007/s12035-016-9703-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-016-9703-y</ArticleId><ArticleId IdType="pubmed">26768594</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng X.-L., Feng L., Wang Z.-X., Zhao Y.-E., Zhan Q., Wu X.-M., Xiao B., Shu Y. The Runx1/Notch1 Signaling Pathway Participates in M1/M2 Microglia Polarization in a Mouse Model of Temporal Lobe Epilepsy and in BV-2 Cells. Neurochem. Res. 2020;45:2204&#x2013;2216. doi: 10.1007/s11064-020-03082-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-020-03082-3</ArticleId><ArticleId IdType="pubmed">32632543</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackerman K., Fiddler J., Soh T., Clarke S. BV-2 Microglial Cells Used in a Model of Neuroinflammation. FASEB J. 2015;29:608.2. doi: 10.1096/fasebj.29.1_supplement.608.2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fasebj.29.1_supplement.608.2</ArticleId></ArticleIdList></Reference><Reference><Citation>Righi M., Mori L., De Libero G., Sironi M., Biondi A., Mantovani A., Donini S.D., Ricciardi-Castagnoli P. Monokine production by microglial cell clones. Eur. J. Immunol. 1989;19:1443&#x2013;1448. doi: 10.1002/eji.1830190815.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.1830190815</ArticleId><ArticleId IdType="pubmed">2789141</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Liu W., Alizadeh D., Zhao D., Farrukh O., Lin J., Badie S.A., Badie B. S100B attenuates microglia activation in gliomas: Possible role of STAT3 pathway. Glia. 2011;59:486&#x2013;498. doi: 10.1002/glia.21118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.21118</ArticleId><ArticleId IdType="pmc">PMC3079926</ArticleId><ArticleId IdType="pubmed">21264954</ArticleId></ArticleIdList></Reference><Reference><Citation>Dukic-Stefanovic S., Gasic-Milenkovic J., Deuther-Conrad W., M&#xfc;nch G. Signal transduction pathways in mouse microglia N-11 cells activated by advanced glycation endproducts (AGEs) J. Neurochem. 2003;87:44&#x2013;55. doi: 10.1046/j.1471-4159.2003.01988.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.2003.01988.x</ArticleId><ArticleId IdType="pubmed">12969251</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaz A.R., Pinto S., Ezequiel C., Cunha C., Carvalho L.A., Moreira R., Brites D. Phenotypic effects of wild-type and mutant SOD1 expression in n9 murine microglia at steady state, inflammatory and immunomodulatory conditions. Front. Cell. Neurosci. 2019 doi: 10.3389/fncel.2019.00109.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2019.00109</ArticleId><ArticleId IdType="pmc">PMC6465643</ArticleId><ArticleId IdType="pubmed">31024256</ArticleId></ArticleIdList></Reference><Reference><Citation>Corradin S.B., Mau&#xeb;l J., Donini S.D., Quattrocchi E., Ricciardi-Castagnoli P. Inducible nitric oxide synthase activity of cloned murine microglial cells. Glia. 1993;7:255&#x2013;262. doi: 10.1002/glia.440070309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.440070309</ArticleId><ArticleId IdType="pubmed">7681038</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunawardena D., Shanmugam K., Low M., Bennett L., Govindaraghavan S., Head R., Ooi L., M&#xfc;nch G. Determination of anti-inflammatory activities of standardised preparations of plant- and mushroom-based foods. Eur. J. Nutr. 2014;53:335&#x2013;343. doi: 10.1007/s00394-013-0531-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00394-013-0531-9</ArticleId><ArticleId IdType="pubmed">23653285</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong A., Dukic-Stefanovic S., Gasic-Milenkovic J., Schinzel R., Wiesinger H., Riederer P., M&#xfc;nch G., Biology N.C., Leipzig I., Riederer P., et al. Anti-inflammatory antioxidants attenuate the expression of inducible nitric oxide synthase mediated by advanced glycation endproducts in murine microglia. Eur. J. Neurosci. 2001;14:1961&#x2013;1967. doi: 10.1046/j.0953-816x.2001.01820.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.0953-816x.2001.01820.x</ArticleId><ArticleId IdType="pubmed">11860491</ArticleId></ArticleIdList></Reference><Reference><Citation>Khazaei M.R., Habibi-Rezaei M., Karimzadeh F., Moosavi-Movahedi A.A., Sarrafnejhad A.A., Sabouni F., Bakhti M. Microglial Cell Death Induced by Glycated Bovine Serum Albumin: Nitric Oxide Involvement. J. Biochem. 2008;144:197&#x2013;206. doi: 10.1093/jb/mvn059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jb/mvn059</ArticleId><ArticleId IdType="pubmed">18463114</ArticleId></ArticleIdList></Reference><Reference><Citation>Berbaum K., Shanmugam K., Stuchbury G., Wiede F., K&#xf6;rner H., M&#xfc;nch G. Induction of novel cytokines and chemokines by advanced glycation endproducts determined with a cytometric bead array. Cytokine. 2008;41:198&#x2013;203. doi: 10.1016/j.cyto.2007.11.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2007.11.012</ArticleId><ArticleId IdType="pubmed">18166486</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagai A., Nakagawa E., Hatori K., Choi H.B., McLarnon J.G., Lee M.A., Kim S.U. Generation and characterization of immortalized human microglial cell lines: Expression of cytokines and chemokines. Neurobiol. Dis. 2001;8:1057&#x2013;1068. doi: 10.1006/nbdi.2001.0437.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/nbdi.2001.0437</ArticleId><ArticleId IdType="pubmed">11741401</ArticleId></ArticleIdList></Reference><Reference><Citation>Bayarsaikhan E., Bayarsaikhan D., Lee J., Son M., Oh S., Moon J., Park H.-J., Roshini A., Kim S.U., Song B.-J., et al. Microglial AGE-albumin is critical for neuronal death in Parkinson&#x2019;s disease: A possible implication for theranostics. Int. J. Nanomed. 2016;10:281&#x2013;292. doi: 10.2147/IJN.S95077.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJN.S95077</ArticleId><ArticleId IdType="pmc">PMC5003553</ArticleId><ArticleId IdType="pubmed">27601894</ArticleId></ArticleIdList></Reference><Reference><Citation>Janabi N., Peudenier S., H&#xe9;ron B., Ng K.H., Tardieu M. Establishment of human microglial cell lines after transfection of primary cultures of embryonic microglial cells with the SV40 large T antigen. Neurosci. Lett. 1995;195:105&#x2013;108. doi: 10.1016/0304-3940(94)11792-H.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0304-3940(94)11792-H</ArticleId><ArticleId IdType="pubmed">7478261</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin S., Vincent J.P., Mazella J. Involvement of the neurotensin receptor-3 in the neurotensin-induced migration of human microglia. J. Neurosci. 2003;23:1198&#x2013;1205. doi: 10.1523/JNEUROSCI.23-04-01198.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.23-04-01198.2003</ArticleId><ArticleId IdType="pmc">PMC6742286</ArticleId><ArticleId IdType="pubmed">12598608</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernhart E., Kollroser M., Rechberger G., Reicher H., Heinemann A., Schratl P., Hallstr&#xf6;m S., Wintersperger A., Nusshold C., DeVaney T., et al. Lysophosphatidic acid receptor activation affects the C13NJ microglia cell line proteome leading to alterations in glycolysis, motility, and cytoskeletal architecture. Proteomics. 2010;10:141&#x2013;158. doi: 10.1002/pmic.200900195.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pmic.200900195</ArticleId><ArticleId IdType="pmc">PMC4060044</ArticleId><ArticleId IdType="pubmed">19899077</ArticleId></ArticleIdList></Reference><Reference><Citation>Janabi N., Di Stefano M., Wallon C., Hery C., Chiodi F., Tardieu M. Induction of human immunodeficiency virus type 1 replication in human glial cells after proinflammatory cytokines stimulation: Effect of IFN&#x3b3;, IL1&#x3b2;, and TNF&#x3b1; on differentiation and chemokine production in glial cells. Glia. 1998;23:304&#x2013;315. doi: 10.1002/(SICI)1098-1136(199808)23:4&lt;304::AID-GLIA3&gt;3.0.CO;2-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1098-1136(199808)23:4&lt;304::AID-GLIA3&gt;3.0.CO;2-2</ArticleId><ArticleId IdType="pubmed">9671961</ArticleId></ArticleIdList></Reference><Reference><Citation>Li B., Bedard K., Sorce S., Hinz B., Dubois-Dauphin M., Krause K.H. NOX4 expression in human microglia leads to constitutive generation of reactive oxygen species and to constitutive il-6 expression. J. Innate Immun. 2009;1:570&#x2013;581. doi: 10.1159/000235563.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000235563</ArticleId><ArticleId IdType="pubmed">20375612</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Hjorth E., Zhu M., Calzarossa C., Samuelsson E.-B., Schultzberg M., &#xc5;kesson E. Interplay between human microglia and neural stem/progenitor cells in an allogeneic co-culture model. J. Cell. Mol. Med. 2013;17:1434&#x2013;1443. doi: 10.1111/jcmm.12123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.12123</ArticleId><ArticleId IdType="pmc">PMC4117556</ArticleId><ArticleId IdType="pubmed">24034597</ArticleId></ArticleIdList></Reference><Reference><Citation>Hjorth E., Zhu M., Toro V.C., Vedin I., Palmblad J., Cederholm T., Freund-Levi Y., Faxen-Irving G., Wahlund L.-O., Basun H., et al. Omega-3 fatty acids enhance phagocytosis of Alzheimer&#x2019;s disease-related amyloid-&#x3b2;42 by human microglia and decrease inflammatory markers. J. Alzheimers Dis. 2013;35:697&#x2013;713. doi: 10.3233/JAD-130131.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-130131</ArticleId><ArticleId IdType="pubmed">23481688</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindberg C., Crisby M., Winblad B., Schultzberg M. Effects of statins on microglia. J. Neurosci. Res. 2005;82:10&#x2013;19. doi: 10.1002/jnr.20615.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.20615</ArticleId><ArticleId IdType="pubmed">16118799</ArticleId></ArticleIdList></Reference><Reference><Citation>Hjorth E., Frenkel D., Weiner H., Schultzberg M. Effects of immunomodulatory substances on phagocytosis of abeta(1-42) by human microglia. Int. J. Alzheimers. Dis. 2010;2010:798424. doi: 10.4061/2010/798424.</Citation><ArticleIdList><ArticleId IdType="doi">10.4061/2010/798424</ArticleId><ArticleId IdType="pmc">PMC2925296</ArticleId><ArticleId IdType="pubmed">20798889</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaikh S.B., Uy B., Perera A., Nicholson L.F.B. AGEs-RAGE mediated up-regulation of connexin43 in activated human microglial CHME-5 cells. Neurochem. Int. 2012;60:640&#x2013;651. doi: 10.1016/j.neuint.2012.02.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2012.02.023</ArticleId><ArticleId IdType="pubmed">22417726</ArticleId></ArticleIdList></Reference><Reference><Citation>Bigl K., Gaunitz F., Schmitt A., Rothemund S., Schliebs R., Munch G., Arendt T., M&#xfc;nch G., Arendt T. Cytotoxicity of advanced glycation endproducts in human micro- and astroglial cell lines depends on the degree of protein glycation. J. Neural Transm. 2008;115:1545&#x2013;1556. doi: 10.1007/s00702-008-0126-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00702-008-0126-4</ArticleId><ArticleId IdType="pubmed">18825304</ArticleId></ArticleIdList></Reference><Reference><Citation>Giulian D., Baker T.J.J. Characterization of ameboid microglia isolated from developing mammalian brain. J. Neurosci. 1986;6:2163&#x2013;2178. doi: 10.1523/JNEUROSCI.06-08-02163.1986.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.06-08-02163.1986</ArticleId><ArticleId IdType="pmc">PMC6568755</ArticleId><ArticleId IdType="pubmed">3018187</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang Y., Le W. Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases. Mol. Neurobiol. 2016;53:1181&#x2013;1194. doi: 10.1007/s12035-014-9070-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-014-9070-5</ArticleId><ArticleId IdType="pubmed">25598354</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao K., Zu H. bing Microglial polarization: Novel therapeutic mechanism against Alzheimer&#x2019;s disease. Inflammopharmacology. 2020;28:95&#x2013;110. doi: 10.1007/s10787-019-00613-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10787-019-00613-5</ArticleId><ArticleId IdType="pubmed">31264132</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakagawa Y., Chiba K. Diversity and plasticity of microglial cells in psychiatric and neurological disorders. Pharmacol. Ther. 2015;154:21&#x2013;35. doi: 10.1016/j.pharmthera.2015.06.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2015.06.010</ArticleId><ArticleId IdType="pubmed">26129625</ArticleId></ArticleIdList></Reference><Reference><Citation>Boje K.M.M., Arora P.K.K. Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res. 1992;587:250&#x2013;256. doi: 10.1016/0006-8993(92)91004-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0006-8993(92)91004-X</ArticleId><ArticleId IdType="pubmed">1381982</ArticleId></ArticleIdList></Reference><Reference><Citation>Colton C.A., Gilbert D.L. Production of superoxide anions by a CNS macrophage, the microglia. FEBS Lett. 1987;223:284&#x2013;288. doi: 10.1016/0014-5793(87)80305-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0014-5793(87)80305-8</ArticleId><ArticleId IdType="pubmed">2822487</ArticleId></ArticleIdList></Reference><Reference><Citation>Takata K., Kitamura Y., Saeki M., Terada M., Kagitani S., Kitamura R., Fujikawa Y., Maelicke A., Tomimoto H., Taniguchi T., et al. Galantamine-induced amyloid-&#x3b2; clearance mediated via stimulation of microglial nicotinic acetylcholine receptors. J. Biol. Chem. 2010;285:40180&#x2013;40191. doi: 10.1074/jbc.M110.142356.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.142356</ArticleId><ArticleId IdType="pmc">PMC3001000</ArticleId><ArticleId IdType="pubmed">20947502</ArticleId></ArticleIdList></Reference><Reference><Citation>Koenigsknecht-Talboo J., Landreth G.E. Microglial phagocytosis induced by fibrillar &#x3b2;-amyloid and IgGs are differentially regulated by proinflammatory cytokines. J. Neurosci. 2005;25:8240&#x2013;8249. doi: 10.1523/JNEUROSCI.1808-05.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1808-05.2005</ArticleId><ArticleId IdType="pmc">PMC6725530</ArticleId><ArticleId IdType="pubmed">16148231</ArticleId></ArticleIdList></Reference><Reference><Citation>Maezawa I., Zimin P.I., Wulff H., Jin L.-W. Amyloid-beta protein oligomer at low nanomolar concentrations activates microglia and induces microglial neurotoxicity. J. Biol. Chem. 2011;286:3693&#x2013;3706. doi: 10.1074/jbc.M110.135244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.135244</ArticleId><ArticleId IdType="pmc">PMC3030372</ArticleId><ArticleId IdType="pubmed">20971854</ArticleId></ArticleIdList></Reference><Reference><Citation>He W., Yuan K., Ji B., Han Y., Li J. Protective effects of curcumin against neuroinflammation induced by A&#x3b2;25-35 in primary rat microglia: Modulation of high-mobility group box 1, toll-like receptor 4 and receptor for advanced glycation end products expression. Ann. Transl. Med. 2020;8:88. doi: 10.21037/atm.2019.12.147.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/atm.2019.12.147</ArticleId><ArticleId IdType="pmc">PMC7048970</ArticleId><ArticleId IdType="pubmed">32175381</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen C., Ma Y., Zeng Z., Yin Q., Hong Y., Hou X., Liu X. RAGE-Specific Inhibitor FPS-ZM1 Attenuates AGEs-Induced Neuroinflammation and Oxidative Stress in Rat Primary Microglia. Neurochem. Res. 2017;42:2902&#x2013;2911. doi: 10.1007/s11064-017-2321-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-017-2321-x</ArticleId><ArticleId IdType="pubmed">28664403</ArticleId></ArticleIdList></Reference><Reference><Citation>Deane R., Singh I., Sagare A.P., Bell R.D., Ross N.T., LaRue B., Love R., Perry S., Paquette N., Deane R.J., et al. A multimodal RAGE-specific inhibitor reduces amyloid &#x3b2;-mediated brain disorder in a mouse model of Alzheimer disease. J. Clin. Investig. 2012;122:1377&#x2013;1392. doi: 10.1172/JCI58642.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI58642</ArticleId><ArticleId IdType="pmc">PMC3314449</ArticleId><ArticleId IdType="pubmed">22406537</ArticleId></ArticleIdList></Reference><Reference><Citation>Murray P.J., Allen J.E., Biswas S.K., Fisher E.A., Gilroy D.W., Goerdt S., Gordon S., Hamilton J.A., Ivashkiv L.B., Lawrence T., et al. Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines. Immunity. 2014;41:14&#x2013;20. doi: 10.1016/j.immuni.2014.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2014.06.008</ArticleId><ArticleId IdType="pmc">PMC4123412</ArticleId><ArticleId IdType="pubmed">25035950</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuchiya S., Yamabe M., Yamaguchi Y., Kobayashi Y., Konno T., Tada K. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1) Int. J. Cancer. 1980;26:171&#x2013;176. doi: 10.1002/ijc.2910260208.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ijc.2910260208</ArticleId><ArticleId IdType="pubmed">6970727</ArticleId></ArticleIdList></Reference><Reference><Citation>Chanput W., Mes J.J., Wichers H.J. THP-1 cell line: An in vitro cell model for immune modulation approach. Int. Immunopharmacol. 2014;23:37&#x2013;45. doi: 10.1016/j.intimp.2014.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2014.08.002</ArticleId><ArticleId IdType="pubmed">25130606</ArticleId></ArticleIdList></Reference><Reference><Citation>Auwerx J. The human leukemia cell line, THP-1: A multifacetted model for the study of monocyte-macrophage differentiation. Experientia. 1991;47:22&#x2013;31. doi: 10.1007/BF02041244.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02041244</ArticleId><ArticleId IdType="pubmed">1999239</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin Z. The use of THP-1 cells as a model for mimicking the function and regulation of monocytes and macrophages in the vasculature. Atherosclerosis. 2012;221:2&#x2013;11. doi: 10.1016/j.atherosclerosis.2011.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.atherosclerosis.2011.09.003</ArticleId><ArticleId IdType="pubmed">21978918</ArticleId></ArticleIdList></Reference><Reference><Citation>Perty&#x144;ska-Marczewska M., Kiriakidis S., Wait R., Beech J., Feldmann M., Paleolog E.M. Advanced glycation end products upregulate angiogenic and pro-inflammatory cytokine production in human monocyte/macrophages. Cytokine. 2004;28:35&#x2013;47. doi: 10.1016/j.cyto.2004.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2004.06.006</ArticleId><ArticleId IdType="pubmed">15341924</ArticleId></ArticleIdList></Reference><Reference><Citation>Abordo E.A., Thornalley P.J. Synthesis and secretion of tumour necrosis factor-&#x3b1; by human monocytic THP-1 cells and chemotaxis induced by human serum albumin derivatives modified with methylglyoxal and glucose-derived advanced glycation endproducts. Immunol. Lett. 1997;58:139&#x2013;147. doi: 10.1016/S0165-2478(97)00080-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0165-2478(97)00080-1</ArticleId><ArticleId IdType="pubmed">9293394</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai W., Zhou J., Zhou N., Liu Q., Cui J., Zou W., Zhang W. Hypoxia-increased RAGE expression regulates chemotaxis and pro-inflammatory cytokines release through nuclear translocation of NF-&#x3ba; B and HIF1&#x3b1; in THP-1 cells. Biochem. Biophys. Res. Commun. 2018;495:2282&#x2013;2288. doi: 10.1016/j.bbrc.2017.12.084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2017.12.084</ArticleId><ArticleId IdType="pubmed">29258824</ArticleId></ArticleIdList></Reference><Reference><Citation>Figarola J.L., Shanmugam N., Natarajan R., Rahbar S. Anti-inflammatory effects of the advanced glycation end product inhibitor LR-90 in human monocytes. Diabetes. 2007;56:647&#x2013;655. doi: 10.2337/db06-0936.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db06-0936</ArticleId><ArticleId IdType="pubmed">17327432</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J., Bai W., Liu Q., Cui J., Zhang W. Intermittent Hypoxia Enhances THP-1 Monocyte Adhesion and Chemotaxis and Promotes M1 Macrophage Polarization via RAGE. Biomed Res. Int. 2018;2018:1650456. doi: 10.1155/2018/1650456.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/1650456</ArticleId><ArticleId IdType="pmc">PMC6196992</ArticleId><ArticleId IdType="pubmed">30402462</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y., Toure F., Qu W., Lin L., Song F., Shen X., Rosario R., Garcia J., Schmidt A.M., Yan S.-F. Advanced glycation end product (AGE)-receptor for age (RAGE) signaling and up-regulation of Egr-1 in hypoxic macrophages. J. Biol. Chem. 2010;285:23233&#x2013;23240. doi: 10.1074/jbc.M110.117457.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.117457</ArticleId><ArticleId IdType="pmc">PMC2906316</ArticleId><ArticleId IdType="pubmed">20507991</ArticleId></ArticleIdList></Reference><Reference><Citation>Bezold V., Rosenstock P., Scheffler J., Geyer H., Horstkorte R., Bork K. Glycation of macrophages induces expression of pro-inflammatory cytokines and reduces phagocytic efficiency. Aging. 2019;11:5258&#x2013;5275. doi: 10.18632/aging.102123.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.102123</ArticleId><ArticleId IdType="pmc">PMC6682540</ArticleId><ArticleId IdType="pubmed">31386629</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorenkamp M., M&#xfc;ller J.P., Shanmuganathan K.S., Schulten H., M&#xfc;ller N., L&#xf6;ffler I., M&#xfc;ller U.A., Wolf G., B&#xf6;hmer F.D., Godfrey R., et al. Hyperglycaemia-induced methylglyoxal accumulation potentiates VEGF resistance of diabetic monocytes through the aberrant activation of tyrosine phosphatase SHP-2/SRC kinase signalling axis. Sci. Rep. 2018;8:14684. doi: 10.1038/s41598-018-33014-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-33014-9</ArticleId><ArticleId IdType="pmc">PMC6168515</ArticleId><ArticleId IdType="pubmed">30279491</ArticleId></ArticleIdList></Reference><Reference><Citation>Shanmugam N., Kim Y.S., Lanting L., Natarajan R. Regulation of cyclooxygenase-2 expression in monocytes by ligation of the receptor for advanced glycation end products. J. Biol. Chem. 2003;278:34834&#x2013;34844. doi: 10.1074/jbc.M302828200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M302828200</ArticleId><ArticleId IdType="pubmed">12837757</ArticleId></ArticleIdList></Reference><Reference><Citation>Abordo E.A., Westwood M.E., Thornalley P.J. Synthesis and secretion of macrophage colony stimulating factor by mature human monocytes and human monocytic THP-1 cells induced by human serum albumin derivatives modified with methylglyoxal and glucose-derived advanced glycation endproducts. Immunol. Lett. 1996;53:7&#x2013;13. doi: 10.1016/0165-2478(96)02601-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0165-2478(96)02601-6</ArticleId><ArticleId IdType="pubmed">8946211</ArticleId></ArticleIdList></Reference><Reference><Citation>Iida Y., Miyata T., Inagi R., Sugiyama S., Maeda K. &#x3b2;2-Microglobulin modified with advanced glycation end products induces interleukin-6 from human macrophages: Role in the pathogenesis of hemodialysis-associated amyloidosis. Biochem. Biophys. Res. Commun. 1994;201:1235&#x2013;1241. doi: 10.1006/bbrc.1994.1837.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/bbrc.1994.1837</ArticleId><ArticleId IdType="pubmed">8024566</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirstein M., Brett J., Radoff S., Ogawa S., Stern D., Vlassara H. Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: Role in vascular disease of diabetes and aging. Proc. Natl. Acad. Sci. USA. 1990;87:9010&#x2013;9014. doi: 10.1073/pnas.87.22.9010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.87.22.9010</ArticleId><ArticleId IdType="pmc">PMC55090</ArticleId><ArticleId IdType="pubmed">2247477</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyata T., Inagi R., Iida Y., Sato M., Yamada N., Oda O., Maeda K., Seo H. Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleukin-1. J. Clin. Investig. 1994;93:521&#x2013;528. doi: 10.1172/JCI117002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI117002</ArticleId><ArticleId IdType="pmc">PMC293873</ArticleId><ArticleId IdType="pubmed">8113390</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan W., Wu H. Protective effects of curcumin on methylglyoxal-induced oxidative DNA damage and cell injury in human mononuclear cells. Acta Pharmacol. Sin. 2006;27:1192&#x2013;1198. doi: 10.1111/j.1745-7254.2006.00374.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1745-7254.2006.00374.x</ArticleId><ArticleId IdType="pubmed">16923340</ArticleId></ArticleIdList></Reference><Reference><Citation>Valencia J.V., Mone M., Koehne C., Rediske J., Hughes T.E. Binding of receptor for advanced glycation end products (RAGE) ligands is not sufficient to induce inflammatory signals: Lack of activity of endotoxin-free albumin-derived advanced glycation end products. Diabetologia. 2004;47:844&#x2013;852. doi: 10.1007/s00125-004-1392-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00125-004-1392-9</ArticleId><ArticleId IdType="pubmed">15127201</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin X., Liu L., Zhang Y., Xiang Y., Yin G., Lu Y., Shi L., Dong J., Shen C. Advanced glycation end products enhance murine monocyte proliferation in bone marrow and prime them into an inflammatory phenotype through MAPK signaling. J. Diabetes Res. 2018;2018:2527406. doi: 10.1155/2018/2527406.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/2527406</ArticleId><ArticleId IdType="pmc">PMC5885396</ArticleId><ArticleId IdType="pubmed">29765986</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai W., Di Gao Q., Zhu L., Peppa M., He C., Vlassara H. Oxidative stress-inducing carbonyl compounds from common foods: Novel mediators of cellular dysfunction. Mol. Med. 2002;8:337&#x2013;346. doi: 10.1007/BF03402014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03402014</ArticleId><ArticleId IdType="pmc">PMC2040002</ArticleId><ArticleId IdType="pubmed">12393931</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S., Yin L., Xu Z., An F.-M., Liu A.-R., Wang Y., Yao W.-B., Gao X.-D. Inhibiting receptor for advanced glycation end product (AGE) and oxidative stress involved in the protective effect mediated by glucagon-like peptide-1 receptor on AGE induced neuronal apoptosis. Neurosci. Lett. 2016;612:193&#x2013;198. doi: 10.1016/j.neulet.2015.12.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2015.12.007</ArticleId><ArticleId IdType="pubmed">26679229</ArticleId></ArticleIdList></Reference><Reference><Citation>Loske C., Neumann A., Cunningham A.M., Nichol K., Schinzel R., Riederer P., M&#xfc;nch G. Cytotoxicity of advanced glycation endproducts is mediated by oxidative stress. J. Neural Transm. 1998;105:1005&#x2013;1015. doi: 10.1007/s007020050108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s007020050108</ArticleId><ArticleId IdType="pubmed">9869332</ArticleId></ArticleIdList></Reference><Reference><Citation>Nan F., Sun G., Xie W., Ye T., Sun X., Zhou P., Dong X., Sun J., Sun X., Zhang M. Ginsenoside Rb1 mitigates oxidative stress and apoptosis induced by methylglyoxal in SH-SY5Y cells via the PI3K/Akt pathway. Mol. Cell. Probes. 2019;48:101469. doi: 10.1016/j.mcp.2019.101469.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcp.2019.101469</ArticleId><ArticleId IdType="pubmed">31629029</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasu R., Furukawa A., Suzuki K., Takeuchi M., Koriyama Y. The effect of glyceraldehyde-derived advanced glycation end products on &#x3b2;-tubulin-inhibited neurite outgrowth in sh-sy5y human neuroblastoma cells. Nutrients. 2020;12:2958. doi: 10.3390/nu12102958.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12102958</ArticleId><ArticleId IdType="pmc">PMC7601248</ArticleId><ArticleId IdType="pubmed">32992566</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeuchi M., Bucala R., Suzuki T., Ohkubo T., Yamazaki M., Koike T., Kameda Y., Makita Z., Amazaki M.A.Y., Oike T.A.K., et al. Neurotoxicity of Advanced Glycation End-Products for Cultured Cortical Neurons. J. Neuropathol. Exp. Neurol. 2000;59:1094&#x2013;1105. doi: 10.1093/jnen/59.12.1094.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/59.12.1094</ArticleId><ArticleId IdType="pubmed">11138929</ArticleId></ArticleIdList></Reference><Reference><Citation>Smirnova L., Harris G., Delp J., Valadares M., Pamies D., Hogberg H.T., Waldmann T., Leist M., Hartung T. A LUHMES 3D dopaminergic neuronal model for neurotoxicity testing allowing long-term exposure and cellular resilience analysis. Arch. Toxicol. Arch. F&#xfc;r Toxikol. 2016;90:2725&#x2013;2743. doi: 10.1007/s00204-015-1637-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00204-015-1637-z</ArticleId><ArticleId IdType="pmc">PMC5065586</ArticleId><ArticleId IdType="pubmed">26647301</ArticleId></ArticleIdList></Reference><Reference><Citation>Malagelada C., Greene L.A. Chapter 29-PC12 Cells as a model for parkinson&#x2019;s disease research. In: Nass R., Przedborski S.B.T.-P.D., editors. Parkinson&#x2019;s Disease Molecular and Therapeutic Insights from Model Systems. Academic Press; San Diego, CA, USA: 2008. pp. 375&#x2013;387.</Citation></Reference><Reference><Citation>Grau C.M., Greene L.A. Use of PC12 cells and rat superior cervical ganglion sympathetic neurons as models for neuroprotective assays relevant to Parkinson&#x2019;s disease. Methods Mol. Biol. 2012;846:201&#x2013;211. doi: 10.1007/978-1-61779-536-7_18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-61779-536-7_18</ArticleId><ArticleId IdType="pmc">PMC3678375</ArticleId><ArticleId IdType="pubmed">22367813</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee W.-C., Chen Y.-Y., Kan D., Chien C.-L. A neuronal death model: Overexpression of neuronal intermediate filament protein peripherin in PC12 cells. J. Biomed. Sci. 2012;19:8. doi: 10.1186/1423-0127-19-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1423-0127-19-8</ArticleId><ArticleId IdType="pmc">PMC3282651</ArticleId><ArticleId IdType="pubmed">22252275</ArticleId></ArticleIdList></Reference><Reference><Citation>Song T.-Y., Yang N.-C., Chen C.-L., Thi T.L.V. Protective Effects and Possible Mechanisms of Ergothioneine and Hispidin against Methylglyoxal-Induced Injuries in Rat Pheochromocytoma Cells. Oxid. Med. Cell. Longev. 2017;2017:4824371. doi: 10.1155/2017/4824371.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/4824371</ArticleId><ArticleId IdType="pmc">PMC5664345</ArticleId><ArticleId IdType="pubmed">29181125</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo T.-Y., Huang C.-L., Yang J.-M., Huang W.-J., Huang N.-K., Chen Y.-W., Lin R.-J., Yang Y.-C. The role of ribosylated-BSA in regulating PC12 cell viability. Cell Biol. Toxicol. 2012;28:255&#x2013;267. doi: 10.1007/s10565-012-9220-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10565-012-9220-3</ArticleId><ArticleId IdType="pubmed">22543687</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan F., Han G., Wu G. Cytotoxic role of advanced glycation end-products in PC12 cells treated with &#x3b2;-amyloid peptide. Mol. Med. Rep. 2013;8:367&#x2013;372. doi: 10.3892/mmr.2013.1545.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2013.1545</ArticleId><ArticleId IdType="pubmed">23799541</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu M., Zang D., Xu Y., Meng J., Qian S. Protective effect of ISO-1 against advanced glycation end product aggravation of PC12 cell injury induced by A&#x3b2;1-40. Mol. Med. Rep. 2019;20:2135&#x2013;2142. doi: 10.3892/mmr.2019.10483.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2019.10483</ArticleId><ArticleId IdType="pmc">PMC6691208</ArticleId><ArticleId IdType="pubmed">31322215</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S.-M., Hsu C.-L., Chuang H.-C., Shih P.-H., Wu C.-H., Yen G.-C. Inhibitory effect of vanillic acid on methylglyoxal-mediated glycation in apoptotic Neuro-2A cells. Neurotoxicology. 2008;29:1016&#x2013;1022. doi: 10.1016/j.neuro.2008.07.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuro.2008.07.002</ArticleId><ArticleId IdType="pubmed">18706441</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S.-M., Chuang H.-C., Wu C.-H., Yen G.-C. Cytoprotective effects of phenolic acids on methylglyoxal-induced apoptosis in Neuro-2A cells. Mol. Nutr. Food Res. 2008;52:940&#x2013;949. doi: 10.1002/mnfr.200700360.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mnfr.200700360</ArticleId><ArticleId IdType="pubmed">18481334</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee C.-C., Lee B.-H., Wu S.-C. Actinidia callosa peel (kiwi fruit) ethanol extracts protected neural cells apoptosis induced by methylglyoxal through Nrf2 activation. Pharm. Biol. 2014;52:628&#x2013;636. doi: 10.3109/13880209.2013.860555.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/13880209.2013.860555</ArticleId><ArticleId IdType="pubmed">24707974</ArticleId></ArticleIdList></Reference><Reference><Citation>Sevillano N., Gir&#xf3;n M.D., Salido M., Vargas A.M., Vilches J., Salto R. Internalization of the receptor for advanced glycation end products (RAGE) is required to mediate intracellular responses. J. Biochem. 2009;145:21&#x2013;30. doi: 10.1093/jb/mvn137.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jb/mvn137</ArticleId><ArticleId IdType="pubmed">18849572</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu X., Liu H., Liu Y., Chen Y., Liu Y., Yin X. The Antidepressant-Like Effects of Hesperidin in Streptozotocin-Induced Diabetic Rats by Activating Nrf2/ARE/Glyoxalase 1 Pathway. Front. Pharmacol. 2020;11:1325. doi: 10.3389/fphar.2020.01325.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2020.01325</ArticleId><ArticleId IdType="pmc">PMC7485173</ArticleId><ArticleId IdType="pubmed">32982741</ArticleId></ArticleIdList></Reference><Reference><Citation>Sajithlal G., Huttunen H., Rauvala H., Munch G. Receptor for Advanced Glycation End Products Plays a More Important Role in Cellular Survival than in Neurite Outgrowth during Retinoic Acid-induced Differentiation of Neuroblastoma Cells. J. Biol. Chem. 2002;277:6888&#x2013;6897. doi: 10.1074/jbc.M107627200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M107627200</ArticleId><ArticleId IdType="pubmed">11739380</ArticleId></ArticleIdList></Reference><Reference><Citation>Biedler J.L., Helson L., Spengler B.A. Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res. 1973;33:2643&#x2013;2652.</Citation><ArticleIdList><ArticleId IdType="pubmed">4748425</ArticleId></ArticleIdList></Reference><Reference><Citation>Xicoy H., Wieringa B., Martens G.J.M. The SH-SY5Y cell line in Parkinson&#x2019;s disease research: A systematic review. Mol. Neurodegener. 2017;12:10. doi: 10.1186/s13024-017-0149-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-017-0149-0</ArticleId><ArticleId IdType="pmc">PMC5259880</ArticleId><ArticleId IdType="pubmed">28118852</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovalevich J., Langford D. Considerations for the use of SH-SY5Y neuroblastoma cells in neurobiology. Methods Mol. Biol. 2013;1078:9&#x2013;21. doi: 10.1007/978-1-62703-640-5_2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-62703-640-5_2</ArticleId><ArticleId IdType="pmc">PMC5127451</ArticleId><ArticleId IdType="pubmed">23975817</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor-Whiteley T.R., Le Maitre C.L., Duce J.A., Dalton C.F., Smith D.P. Recapitulating Parkinson&#x2019;s disease pathology in a three-dimensional human neural cell culture model. Dis. Model. Mech. 2019;12:dmm038042. doi: 10.1242/dmm.038042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.038042</ArticleId><ArticleId IdType="pmc">PMC6505482</ArticleId><ArticleId IdType="pubmed">30926586</ArticleId></ArticleIdList></Reference><Reference><Citation>Tseng Y.-T., Tsai Y.-H., F&#xfc;l&#xf6;p F., Chang F.-R., Lo Y.-C. 2-Iodo-4&#x2032;-methoxychalcone attenuates methylglyoxal-induced neurotoxicity by activation of GLP-1 receptor and enhancement of neurotrophic signal, antioxidant defense and glyoxalase pathway. Molecules. 2019;24:2249. doi: 10.3390/molecules24122249.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules24122249</ArticleId><ArticleId IdType="pmc">PMC6631972</ArticleId><ArticleId IdType="pubmed">31208152</ArticleId></ArticleIdList></Reference><Reference><Citation>Angeloni C., Malaguti M., Rizzo B., Barbalace M.C., Fabbri D., Hrelia S. Neuroprotective Effect of Sulforaphane against Methylglyoxal Cytotoxicity. Chem. Res. Toxicol. 2015;28:1234&#x2013;1245. doi: 10.1021/acs.chemrestox.5b00067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.chemrestox.5b00067</ArticleId><ArticleId IdType="pubmed">25933243</ArticleId></ArticleIdList></Reference><Reference><Citation>Leclerc E., Fritz G., Weibel M., Heizmann C.W., Galichet A. S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains. J. Biol. Chem. 2007;282:31317&#x2013;31331. doi: 10.1074/jbc.M703951200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M703951200</ArticleId><ArticleId IdType="pubmed">17726019</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng J., Kaur H., Collier T., Chang K., Brooks A.E.S., Allison J.R., Brimble M.A., Hickey A., Birch N.P. Site-specific glycation of A1- 42 affects fibril formation and is neurotoxic. J. Biol. Chem. 2019;294:8806&#x2013;8818. doi: 10.1074/jbc.RA118.006846.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA118.006846</ArticleId><ArticleId IdType="pmc">PMC6552435</ArticleId><ArticleId IdType="pubmed">30996005</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai M.C., Liu W.Y., Liou S.-S., Liu I.-M. A bibenzyl component moscatilin mitigates glycation-mediated damages in an SH-SY5Y cell model of neurodegenerative diseases through AMPK activation and RAGE/NF-&#x3ba;B Pathway Suppression. Molecules. 2020;25:4574. doi: 10.3390/molecules25194574.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules25194574</ArticleId><ArticleId IdType="pmc">PMC7582731</ArticleId><ArticleId IdType="pubmed">33036367</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhla B., Loske C., Garcia de Arriba S., Schinzel R., Huber J., M&#xfc;nch G. Differential effects of &#x201c;Advanced glycation endproducts&#x201d; and &#x3b2;-amyloid peptide on glucose utilization and ATP levels in the neuronal cell line SH-SY5Y. J. Neural Transm. 2004;111:427&#x2013;439. doi: 10.1007/s00702-003-0038-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00702-003-0038-2</ArticleId><ArticleId IdType="pubmed">14991463</ArticleId></ArticleIdList></Reference><Reference><Citation>De Arriba S.G., Loske C., Meiners I., Fleischer G., Lobisch M., Wessel K., Tritschler H., Schinzel R., M&#xfc;nch G. Advanced Glycation Endproducts Induce Changes in Glucose Consumption, Lactate Production, and ATP Levels in SH-SY5Y Neuroblastoma Cells by a Redox-Sensitive Mechanism. J. Cereb. Blood Flow Metab. 2003;23:1307&#x2013;1313. doi: 10.1097/01.WCB.0000090622.86921.0E.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.WCB.0000090622.86921.0E</ArticleId><ArticleId IdType="pubmed">14600438</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Yu S., Wang C.-Y., Wang Y., Liu H.-X., Cui Y., Zhang L.-D. Advanced glycation end products induce oxidative stress and mitochondrial dysfunction in SH-SY5Y cells. Vitr. Cell. Dev. Biol. -Anim. 2014;51:204&#x2013;209. doi: 10.1007/s11626-014-9823-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11626-014-9823-5</ArticleId><ArticleId IdType="pubmed">25381033</ArticleId></ArticleIdList></Reference><Reference><Citation>Niu G., Guo J., Tian Y., Zhao K., Li J., Xiao Q. &#x3b1;-lipoic acid can greatly alleviate the toxic effect of AGES on SH-SY5Y cells. Int. J. Mol. Med. 2018;41:2855&#x2013;2864. doi: 10.3892/ijmm.2018.3477.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijmm.2018.3477</ArticleId><ArticleId IdType="pubmed">29436603</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L., Wei Y., Wang X., He R. Ribosylation Rapidly Induces &#x3b1;-Synuclein to Form Highly Cytotoxic Molten Globules of Advanced Glycation End Products. PLoS ONE. 2010;5:e9052. doi: 10.1371/journal.pone.0009052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0009052</ArticleId><ArticleId IdType="pmc">PMC2816216</ArticleId><ArticleId IdType="pubmed">20140223</ArticleId></ArticleIdList></Reference><Reference><Citation>Buttiglione M., Vitiello F., Sardella E., Petrone L., Nardulli M., Favia P., d&#x2019;Agostino R., Gristina R. Behaviour of SH-SY5Y neuroblastoma cell line grown in different media and on different chemically modified substrates. Biomaterials. 2007;28:2932&#x2013;2945. doi: 10.1016/j.biomaterials.2007.02.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biomaterials.2007.02.022</ArticleId><ArticleId IdType="pubmed">17391751</ArticleId></ArticleIdList></Reference><Reference><Citation>Korecka J.A., van Kesteren R.E., Blaas E., Spitzer S.O., Kamstra J.H., Smit A.B., Swaab D.F., Verhaagen J., Bossers K. Phenotypic Characterization of Retinoic Acid Differentiated SH-SY5Y Cells by Transcriptional Profiling. PLoS ONE. 2013;8:e63862. doi: 10.1371/journal.pone.0063862.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0063862</ArticleId><ArticleId IdType="pmc">PMC3665836</ArticleId><ArticleId IdType="pubmed">23724009</ArticleId></ArticleIdList></Reference><Reference><Citation>Encinas M., Iglesias M., Liu Y., Wang H., Muhaisen A., Ce&#xf1;a V., Gallego C., Comella J.X. Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophic factor gives rise to fully differentiated, neurotrophic factor-dependent, human neuron-like cells. J. Neurochem. 2000;75:991&#x2013;1003. doi: 10.1046/j.1471-4159.2000.0750991.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.2000.0750991.x</ArticleId><ArticleId IdType="pubmed">10936180</ArticleId></ArticleIdList></Reference><Reference><Citation>Agholme L., Lindstr&#xf6;m T., Kgedal K., Marcusson J., Hallbeck M. An in vitro model for neuroscience: Differentiation of SH-SY5Y cells into cells with morphological and biochemical characteristics of mature neurons. J. Alzheimers Dis. 2010;20:1069&#x2013;1082. doi: 10.3233/JAD-2010-091363.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-2010-091363</ArticleId><ArticleId IdType="pubmed">20413890</ArticleId></ArticleIdList></Reference><Reference><Citation>Constantinescu R., Constantinescu A., Reichmann H., Janetzky B. Neuronal differentiation and long-term culture of the human neuroblastoma line SH-SY5Y. J. Neural Transm. Suppl. 2007;2007:17&#x2013;28. doi: 10.1007/978-3-211-73574-9_3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-211-73574-9_3</ArticleId><ArticleId IdType="pubmed">17982873</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai C., Dai X., Zhu Y., Lian M., Xiao F., Dong F., Zhang Q., Huang Y., Zheng Q. A specific RAGE-binding peptide biopanning from phage display random peptide library that ameliorates symptoms in amyloid &#x3b2; peptide-mediated neuronal disorder. Appl. Microbiol. Biotechnol. 2016;100:825&#x2013;835. doi: 10.1007/s00253-015-7001-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00253-015-7001-7</ArticleId><ArticleId IdType="pubmed">26496918</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzola J.L., Sirover M.A. Reduction of glyceraldehyde-3-phosphate dehydrogenase activity in Alzheimer&#x2019;s disease and in Huntington&#x2019;s disease fibroblasts. J. Neurochem. 2001;76:442&#x2013;449. doi: 10.1046/j.1471-4159.2001.00033.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.2001.00033.x</ArticleId><ArticleId IdType="pubmed">11208907</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzola J.L., Sirover M.A. Subcellular alteration of glyceraldehyde-3-phosphate dehydrogenase in Alzheimer&#x2019;s disease fibroblasts. J. Neurosci. Res. 2003;71:279&#x2013;285. doi: 10.1002/jnr.10484.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.10484</ArticleId><ArticleId IdType="pubmed">12503091</ArticleId></ArticleIdList></Reference><Reference><Citation>Harischandra D.S., Rokad D., Ghaisas S., Verma S., Robertson A., Jin H., Anantharam V., Kanthasamy A., Kanthasamy A.G. Enhanced differentiation of human dopaminergic neuronal cell model for preclinical translational research in Parkinson&#x2019;s disease. Biochim. Biophys. Acta -Mol. Basis Dis. 2020;1866:165533. doi: 10.1016/j.bbadis.2019.165533.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2019.165533</ArticleId><ArticleId IdType="pmc">PMC7010568</ArticleId><ArticleId IdType="pubmed">31442530</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X.-M., Yin M., Zhang M.-H. Cell-based assays for Parkinson&#x2019;s disease using differentiated human LUHMES cells. Acta Pharmacol. Sin. 2014;35:945&#x2013;956. doi: 10.1038/aps.2014.36.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/aps.2014.36</ArticleId><ArticleId IdType="pmc">PMC4088286</ArticleId><ArticleId IdType="pubmed">24989254</ArticleId></ArticleIdList></Reference><Reference><Citation>Park T.I.-H., Schweder P., Lee K., Dieriks B.V., Jung Y., Smyth L., Rustenhoven J., Mee E., Heppner P., Turner C., et al. Isolation and culture of functional adult human neurons from neurosurgical brain specimens. Brain Commun. 2020;2:fcaa171. doi: 10.1093/braincomms/fcaa171.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcaa171</ArticleId><ArticleId IdType="pmc">PMC7660143</ArticleId><ArticleId IdType="pubmed">33215086</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeuchi M., Watai T., Sasaki N., Choei H., Iwaki M., Ashizawa T., Inagaki Y., Yamagishi S.I., Kikuchi S., Riederer P., et al. Neurotoxicity of acetaldehyde-derived advanced glycation end products for cultured cortical neurons. J. Neuropathol. Exp. Neurol. 2003;62:486&#x2013;496. doi: 10.1093/jnen/62.5.486.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnen/62.5.486</ArticleId><ArticleId IdType="pubmed">12769188</ArticleId></ArticleIdList></Reference><Reference><Citation>Stamatovic S.M., Keep R.F., Andjelkovic A.V. Brain endothelial cell-cell junctions: How to &#x201c;open&#x201d; the blood brain barrier. Curr. Neuropharmacol. 2008;6:179&#x2013;192. doi: 10.2174/157015908785777210.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/157015908785777210</ArticleId><ArticleId IdType="pmc">PMC2687937</ArticleId><ArticleId IdType="pubmed">19506719</ArticleId></ArticleIdList></Reference><Reference><Citation>Roux F., Couraud P.-O. Rat Brain Endothelial Cell Lines for the Study of Blood-Brain Barrier Permeability and Transport Functions. Cell. Mol. Neurobiol. 2005;25:41&#x2013;58. doi: 10.1007/s10571-004-1376-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10571-004-1376-9</ArticleId><ArticleId IdType="pubmed">15962508</ArticleId></ArticleIdList></Reference><Reference><Citation>Vu K., Weksler B., Romero I., Couraud P.-O., Gelli A. Immortalized human brain endothelial cell line HCMEC/D3 as a model of the blood-brain barrier facilitates in vitro studies of central nervous system infection by Cryptococcus neoformans. Eukaryot. Cell. 2009;8:1803&#x2013;1807. doi: 10.1128/EC.00240-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/EC.00240-09</ArticleId><ArticleId IdType="pmc">PMC2772405</ArticleId><ArticleId IdType="pubmed">19767445</ArticleId></ArticleIdList></Reference><Reference><Citation>Faria A., Pestana D., Teixeira D., Azevedo J., De Freitas V., Mateus N., Calhau C. Flavonoid transport across RBE4 cells: A blood-brain barrier model. Cell. Mol. Biol. Lett. 2010;15:234&#x2013;241. doi: 10.2478/s11658-010-0006-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.2478/s11658-010-0006-4</ArticleId><ArticleId IdType="pmc">PMC6275689</ArticleId><ArticleId IdType="pubmed">20140760</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrone L., Sbai O., Nawroth P.P., Bierhaus A. The Complexity of Sporadic Alzheimer&#x2019;s Disease Pathogenesis: The Role of RAGE as Therapeutic Target to Promote Neuroprotection by Inhibiting Neurovascular Dysfunction. Int. J. Alzheimers Dis. 2012;2012:734956. doi: 10.1155/2012/734956.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/734956</ArticleId><ArticleId IdType="pmc">PMC3310161</ArticleId><ArticleId IdType="pubmed">22482078</ArticleId></ArticleIdList></Reference><Reference><Citation>Montesano R., Pepper M.S., M&#xf6;hle-Steinlein U., Risau W., Wagner E.F., Orci L. Increased proteolytic activity is responsible for the aberrant morphogenetic behavior of endothelial cells expressing the middle T oncogene. Cell. 1990;62:435&#x2013;445. doi: 10.1016/0092-8674(90)90009-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(90)90009-4</ArticleId><ArticleId IdType="pubmed">2379237</ArticleId></ArticleIdList></Reference><Reference><Citation>Omidi Y., Campbell L., Barar J., Connell D., Akhtar S., Gumbleton M. Evaluation of the immortalised mouse brain capillary endothelial cell line, b. End3, as an in vitro blood&#x2013;brain barrier model for drug uptake and transport studies. Brain Res. 2003;990:95&#x2013;112. doi: 10.1016/S0006-8993(03)03443-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0006-8993(03)03443-7</ArticleId><ArticleId IdType="pubmed">14568334</ArticleId></ArticleIdList></Reference><Reference><Citation>Helms H.C., Abbott N.J., Burek M., Cecchelli R., Couraud P.-O., Deli M.A., F&#xf6;rster C., Galla H.J., Romero I.A., Shusta E.V., et al. In vitro models of the blood-brain barrier: An overview of commonly used brain endothelial cell culture models and guidelines for their use. J. Cereb. Blood Flow Metab. 2016;36:862&#x2013;890. doi: 10.1177/0271678X16630991.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0271678X16630991</ArticleId><ArticleId IdType="pmc">PMC4853841</ArticleId><ArticleId IdType="pubmed">26868179</ArticleId></ArticleIdList></Reference><Reference><Citation>Qosa H., Abuasal B., Romero I., Weksler B., Couraud P.-O., Keller J., Kaddoumi A. Differences in amyloid-&#x3b2; clearance across mouse and human blood&#x2013;brain barrier models: Kinetic analysis and mechanistic modeling. Neuropharmacology. 2014;79:668&#x2013;678. doi: 10.1016/j.neuropharm.2014.01.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2014.01.023</ArticleId><ArticleId IdType="pmc">PMC3965363</ArticleId><ArticleId IdType="pubmed">24467845</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen W., Chan Y., Wan W., Li Y., Zhang C. A&#x3b2;1-42 induces cell damage via RAGE-dependent endoplasmic reticulum stress in bEnd.3 cells. Exp. Cell Res. 2018;362:83&#x2013;89. doi: 10.1016/j.yexcr.2017.11.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2017.11.005</ArticleId><ArticleId IdType="pubmed">29154819</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou H., Jin C., Cui L., Xing H., Liu J., Liao W., Liao H., Yu Y. HMGB1 contributes to the irradiation-induced endothelial barrier injury through receptor for advanced glycation endproducts (RAGE) J. Cell. Physiol. 2018;233:6714&#x2013;6721. doi: 10.1002/jcp.26341.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.26341</ArticleId><ArticleId IdType="pubmed">29215715</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan W., Cao L., Liu L., Zhang C., Kalionis B., Tai X., Li Y., Xia S. A&#x3b2;1-42 oligomer-induced leakage in an in vitro blood-brain barrier model is associated with up-regulation of RAGE and metalloproteinases, and down-regulation of tight junction scaffold proteins. J. Neurochem. 2015;134:382&#x2013;393. doi: 10.1111/jnc.13122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.13122</ArticleId><ArticleId IdType="pubmed">25866188</ArticleId></ArticleIdList></Reference><Reference><Citation>Park R., Kook S.-Y., Park J.-C., Mook-Jung I. A&#x3b2;1-42 reduces P-glycoprotein in the blood-brain barrier through RAGE-NF-&#x3ba;B signaling. Cell Death Dis. 2014;5:e1299. doi: 10.1038/cddis.2014.258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2014.258</ArticleId><ArticleId IdType="pmc">PMC4611731</ArticleId><ArticleId IdType="pubmed">24967961</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C., Chen K., Lu Y., Fang Z., Yu G. Catalpol provides a protective effect on fibrillary A&#x3b2;1&#x2013;42-induced barrier disruption in an in vitro model of the blood&#x2013;brain barrier. Phyther. Res. 2018;32:1047&#x2013;1055. doi: 10.1002/ptr.6043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ptr.6043</ArticleId><ArticleId IdType="pubmed">29479743</ArticleId></ArticleIdList></Reference><Reference><Citation>Youdim K.A., Dobbie M.S., Kuhnle G., Proteggente A.R., Abbott N.J., Rice-Evans C. Interaction between flavonoids and the blood-brain barrier: In vitro studies. J. Neurochem. 2003;85:180&#x2013;192. doi: 10.1046/j.1471-4159.2003.01652.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.2003.01652.x</ArticleId><ArticleId IdType="pubmed">12641740</ArticleId></ArticleIdList></Reference><Reference><Citation>Weksler B.B., Subileau E.A., Perri&#xe8;re N., Charneau P., Holloway K., Leveque M., Tricoire-Leignel H., Nicotra A., Bourdoulous S., Turowski P., et al. Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J. 2005;19:1872&#x2013;1874. doi: 10.1096/fj.04-3458fje.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.04-3458fje</ArticleId><ArticleId IdType="pubmed">16141364</ArticleId></ArticleIdList></Reference><Reference><Citation>Dauchy S., Miller F., Couraud P.-O., Weaver R.J., Weksler B., Romero I.-A., Scherrmann J.-M., De Waziers I., Decl&#xe8;ves X. Expression and transcriptional regulation of ABC transporters and cytochromes P450 in hCMEC/D3 human cerebral microvascular endothelial cells. Biochem. Pharmacol. 2009;77:897&#x2013;909. doi: 10.1016/j.bcp.2008.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2008.11.001</ArticleId><ArticleId IdType="pubmed">19041851</ArticleId></ArticleIdList></Reference><Reference><Citation>Okura T., Kato S., Deguchi Y. Functional expression of organic cation/carnitine transporter 2 (OCTN2/SLC22A5) in human brain capillary endothelial cell line hCMEC/D3, a human blood-brain barrier model. Drug Metab. Pharmacokinet. 2014;29:69&#x2013;74. doi: 10.2133/dmpk.DMPK-13-RG-058.</Citation><ArticleIdList><ArticleId IdType="doi">10.2133/dmpk.DMPK-13-RG-058</ArticleId><ArticleId IdType="pubmed">23877104</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacob A., Potin S., Chapy H., Crete D., Glacial F., Ganeshamoorthy K., Couraud P.-O., Scherrmann J.-M., Decl&#xe8;ves X. Aryl hydrocarbon receptor regulates CYP1B1 but not ABCB1 and ABCG2 in hCMEC/D3 human cerebral microvascular endothelial cells after TCDD exposure. Brain Res. 2015;1613:27&#x2013;36. doi: 10.1016/j.brainres.2015.03.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2015.03.049</ArticleId><ArticleId IdType="pubmed">25858487</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon F., Guyot L., Garcia J., Vilchez G., Bardel C., Chenel M., Tod M., Payen L. Impact of interleukin-6 on drug transporters and permeability in the hCMEC/D3 blood&#x2013;brain barrier model. Fundam. Clin. Pharmacol. 2021;35:397&#x2013;409. doi: 10.1111/fcp.12596.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/fcp.12596</ArticleId><ArticleId IdType="pubmed">32757312</ArticleId></ArticleIdList></Reference><Reference><Citation>Cecchelli R., Berezowski V., Lundquist S., Culot M., Renftel M., Dehouck M.-P., Fenart L. Modelling of the blood-Brain barrier in drug discovery and development. Nat. Rev. Drug Discov. 2007;6:650&#x2013;661. doi: 10.1038/nrd2368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrd2368</ArticleId><ArticleId IdType="pubmed">17667956</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubey S.K., Ram M.S., Krishna K.V., Saha R.N., Singhvi G., Agrawal M., Ajazuddin, Saraf S., Saraf S., Alexander A. Recent Expansions on Cellular Models to Uncover the Scientific Barriers Towards Drug Development for Alzheimer&#x2019;s Disease. Cell. Mol. Neurobiol. 2019;39:181&#x2013;209. doi: 10.1007/s10571-019-00653-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10571-019-00653-z</ArticleId><ArticleId IdType="pubmed">30671696</ArticleId></ArticleIdList></Reference><Reference><Citation>Yarong H., Yao Y., Tsirka S.E., Yu C. Cell-Culture Models of the Blood&#x2013;Brain Barrier. Stroke. 2014;45:2514&#x2013;2526. doi: 10.1161/STROKEAHA.114.005427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.114.005427</ArticleId><ArticleId IdType="pmc">PMC4668829</ArticleId><ArticleId IdType="pubmed">24938839</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong J., Lee J., Lim J., Cho S., An S., Lee M., Yoon N., Seo M., Lim S., Park S. Soluble RAGE attenuates AngII-induced endothelial hyperpermeability by disrupting HMGB1-mediated crosstalk between AT1R and RAGE. Exp. Mol. Med. 2019;51:1&#x2013;15. doi: 10.1038/s12276-019-0312-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s12276-019-0312-5</ArticleId><ArticleId IdType="pmc">PMC6802637</ArticleId><ArticleId IdType="pubmed">31562296</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu T.-Y., Liu C.-L., Chen J.-Y., Hu M.-L. Curcumin ameliorates methylglyoxal-induced alterations of cellular morphology and hyperpermeability in human umbilical vein endothelial cells. J. Funct. Foods. 2013;5:745&#x2013;754. doi: 10.1016/j.jff.2013.01.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jff.2013.01.020</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Y., Gong Y., Liu L., Zhou Y., Fang X., Zhang C., Li Y., Li J. The use of human umbilical vein endothelial cells (HUVECs) as an in vitro model to assess the toxicity of nanoparticles to endothelium: A review. J. Appl. Toxicol. 2017;37:1359&#x2013;1369. doi: 10.1002/jat.3470.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jat.3470</ArticleId><ArticleId IdType="pubmed">28383141</ArticleId></ArticleIdList></Reference><Reference><Citation>Boerma M., Burton G.R., Wang J., Fink L.M., McGehee R.E., Jr., Hauer-Jensen M. Comparative expression profiling in primary and immortalized endothelial cells: Changes in gene expression in response to hydroxy methylglutaryl-coenzyme A reductase inhibition. Blood Coagul. Fibrinolysis. 2006;17:173&#x2013;180. doi: 10.1097/01.mbc.0000220237.99843.a1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.mbc.0000220237.99843.a1</ArticleId><ArticleId IdType="pubmed">16575254</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan J., Zhu C., Hong Y., Sun Z., Fang X., Wu B., Li S. The role of cPLA2 in Methylglyoxal-induced cell apoptosis of HUVECs. Toxicol. Appl. Pharmacol. 2017;323:44&#x2013;52. doi: 10.1016/j.taap.2017.03.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.taap.2017.03.020</ArticleId><ArticleId IdType="pubmed">28341536</ArticleId></ArticleIdList></Reference><Reference><Citation>Do M.H., Lee J.H., Ahn J., Hong M.J., Kim J., Kim S.Y. Isosamidin from Peucedanum japonicum Roots Prevents Methylglyoxal-Induced Glucotoxicity in Human Umbilical Vein Endothelial Cells via Suppression of ROS-Mediated Bax/Bcl-2. Antioxidants. 2020;9:531. doi: 10.3390/antiox9060531.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox9060531</ArticleId><ArticleId IdType="pmc">PMC7346203</ArticleId><ArticleId IdType="pubmed">32560521</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;nch G., Apelt J., Kientsch-Engel R., Stahl P., L&#xfc;th H.J., Schliebs R. Advanced glycation endproducts and pro-inflammatory cytokines in transgenic Tg2576 mice with amyloid plaque pathology. J. Neurochem. 2003;86:283&#x2013;289. doi: 10.1046/j.1471-4159.2003.01837.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.2003.01837.x</ArticleId><ArticleId IdType="pubmed">12871569</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishibashi Y., Matsui T., Nakamura N., Sotokawauchi A., Higashimoto Y., Yamagishi S.-I. Methylglyoxal-derived hydroimidazolone-1 evokes inflammatory reactions in endothelial cells via an interaction with receptor for advanced glycation end products. Diabetes Vasc. Dis. Res. 2017;14:450&#x2013;453. doi: 10.1177/1479164117715855.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1479164117715855</ArticleId><ArticleId IdType="pubmed">28631505</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeuchi A., Yamamoto Y., Munesue S., Harashima A., Watanabe T., Yonekura H., Yamamoto H., Tsuchiya H. Low molecular weight heparin suppresses receptor for advanced glycation end products-mediated expression of malignant phenotype in human fibrosarcoma cells. Cancer Sci. 2013;104:740&#x2013;749. doi: 10.1111/cas.12133.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cas.12133</ArticleId><ArticleId IdType="pmc">PMC7657155</ArticleId><ArticleId IdType="pubmed">23421467</ArticleId></ArticleIdList></Reference><Reference><Citation>Myint K.-M., Yamamoto Y., Doi T., Kato I., Harashima A., Yonekura H., Watanabe T., Shinohara H., Takeuchi M., Tsuneyama K., et al. RAGE Control of Diabetic Nephropathy in a Mouse Model. Diabetes. 2006;55:2510&#x2013;2522. doi: 10.2337/db06-0221.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db06-0221</ArticleId><ArticleId IdType="pubmed">16936199</ArticleId></ArticleIdList></Reference><Reference><Citation>Franke S., R&#xfc;ster C., Pester J., Hofmann G., Oelzner P., Wolf G. Advanced glycation end products affect growth and function of osteoblasts. Clin. Exp. Rheumatol. 2011;29:650&#x2013;660.</Citation><ArticleIdList><ArticleId IdType="pubmed">21906430</ArticleId></ArticleIdList></Reference><Reference><Citation>Simard E., S&#xf6;llradl T., Maltais J.-S., Boucher J., D&#x2019;Orl&#xe9;ans-Juste P., Grandbois M. Receptor for Advanced Glycation End-Products Signaling Interferes with the Vascular Smooth Muscle Cell Contractile Phenotype and Function. PLoS ONE. 2015;10:e0128881. doi: 10.1371/journal.pone.0128881.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0128881</ArticleId><ArticleId IdType="pmc">PMC4527751</ArticleId><ArticleId IdType="pubmed">26248341</ArticleId></ArticleIdList></Reference><Reference><Citation>Talalay P., Dinkova-Kostova A.T., Holtzclaw W.D. Importance of phase 2 gene regulation in protection against electrophile and reactive oxygen toxicity and carcinogenesis. Adv. Enzym. Regul. 2003;43:121&#x2013;134. doi: 10.1016/S0065-2571(02)00038-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0065-2571(02)00038-9</ArticleId><ArticleId IdType="pubmed">12791387</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J.-M., Johnson J.A. An important role of Nrf2-ARE pathway in the cellular defense mechanism. BMB Rep. 2004;37:139&#x2013;143. doi: 10.5483/BMBRep.2004.37.2.139.</Citation><ArticleIdList><ArticleId IdType="doi">10.5483/BMBRep.2004.37.2.139</ArticleId><ArticleId IdType="pubmed">15469687</ArticleId></ArticleIdList></Reference><Reference><Citation>Baeuerle P.A. Pro-inflammatory signaling: Last pieces in the NF-kappaB puzzle? Curr. Biol. 1998;8:R19&#x2013;R22. doi: 10.1016/S0960-9822(98)70010-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0960-9822(98)70010-7</ArticleId><ArticleId IdType="pubmed">9427616</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H., Forman H.J. Reexamination of the electrophile response element sequences and context reveals a lack of consensus in gene function. Biochim. Biophys. Acta. 2010;1799:496&#x2013;501. doi: 10.1016/j.bbagrm.2010.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbagrm.2010.05.003</ArticleId><ArticleId IdType="pmc">PMC2893253</ArticleId><ArticleId IdType="pubmed">20478426</ArticleId></ArticleIdList></Reference><Reference><Citation>Boerboom A.-M.J.F., Vermeulen M., van der Woude H., Bremer B.I., Lee-Hilz Y.Y., Kampman E., van Bladeren P.J., Rietjens I.M.C.M., Aarts J.M.M.J.G. Newly constructed stable reporter cell lines for mechanistic studies on electrophile-responsive element-mediated gene expression reveal a role for flavonoid planarity. Biochem. Pharmacol. 2006;72:217&#x2013;226. doi: 10.1016/j.bcp.2006.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2006.04.002</ArticleId><ArticleId IdType="pubmed">16756964</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Linden S.C., von Bergh A.R.M., van Vught-Lussenburg B.M.A., Jonker L.R.A., Teunis M., Krul C.A.M., van der Burg B. Development of a panel of high-throughput reporter-gene assays to detect genotoxicity and oxidative stress. Mutat. Res. Toxicol. Environ. Mutagen. 2014;760:23&#x2013;32. doi: 10.1016/j.mrgentox.2013.09.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mrgentox.2013.09.009</ArticleId><ArticleId IdType="pubmed">24362253</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller S.C., Huang R., Sakamuru S., Shukla S.J., Attene-Ramos M.S., Shinn P., Van Leer D., Leister W., Austin C.P., Xia M. Identification of known drugs that act as inhibitors of NF-&#x3ba;B signaling and their mechanism of action. Biochem. Pharmacol. 2010;79:1272&#x2013;1280. doi: 10.1016/j.bcp.2009.12.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2009.12.021</ArticleId><ArticleId IdType="pmc">PMC2834878</ArticleId><ArticleId IdType="pubmed">20067776</ArticleId></ArticleIdList></Reference><Reference><Citation>Soldner F., Hockemeyer D., Beard C., Gao Q., Bell G.W., Cook E.G., Hargus G., Blak A., Cooper O., Mitalipova M., et al. Parkinson&#x2019;s Disease Patient-Derived Induced Pluripotent Stem Cells Free of Viral Reprogramming Factors. Cell. 2009;136:964&#x2013;977. doi: 10.1016/j.cell.2009.02.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2009.02.013</ArticleId><ArticleId IdType="pmc">PMC2787236</ArticleId><ArticleId IdType="pubmed">19269371</ArticleId></ArticleIdList></Reference><Reference><Citation>Park I.H., Arora N., Huo H., Maherali N., Ahfeldt T., Shimamura A., Lensch M.W., Cowan C., Hochedlinger K., Daley G.Q. Disease-Specific Induced Pluripotent Stem Cells. Cell. 2008;134:877&#x2013;886. doi: 10.1016/j.cell.2008.07.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2008.07.041</ArticleId><ArticleId IdType="pmc">PMC2633781</ArticleId><ArticleId IdType="pubmed">18691744</ArticleId></ArticleIdList></Reference><Reference><Citation>Devine M.J., Ryten M., Vodicka P., Thomson A.J., Burdon T., Houlden H., Cavaleri F., Nagano M., Drummond N.J., Taanman J.W., et al. Parkinson&#x2019;s disease induced pluripo.tent stem cells with triplication of the &#x3b1;-synuclein locus. Nat. Commun. 2011;2:440. doi: 10.1038/ncomms1453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms1453</ArticleId><ArticleId IdType="pmc">PMC3265381</ArticleId><ArticleId IdType="pubmed">21863007</ArticleId></ArticleIdList></Reference><Reference><Citation>Sommer A., Maxreiter F., Krach F., Fadler T., Grosch J., Maroni M., Graef D., Eberhardt E., Riemenschneider M.J., Yeo G.W., et al. Th17 Lymphocytes Induce Neuronal Cell Death in a Human iPSC-Based Model of Parkinson&#x2019;s Disease. Cell Stem Cell. 2018;23:123&#x2013;131. doi: 10.1016/j.stem.2018.06.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2018.06.015</ArticleId><ArticleId IdType="pubmed">29979986</ArticleId></ArticleIdList></Reference><Reference><Citation>Kondo T., Asai M., Tsukita K., Kutoku Y., Ohsawa Y., Sunada Y., Imamura K., Egawa N., Yahata N., Okita K., et al. Modeling Alzheimer&#x2019;s disease with iPSCs reveals stress phenotypes associated with intracellular A&#x3b2; and differential drug responsiveness. Cell Stem Cell. 2013;12:487&#x2013;496. doi: 10.1016/j.stem.2013.01.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2013.01.009</ArticleId><ArticleId IdType="pubmed">23434393</ArticleId></ArticleIdList></Reference><Reference><Citation>Sproul A.A., Jacob S., Pre D., Kim S.H., Nestor M.W., Navarro-Sobrino M., Santa-Maria I., Zimmer M., Aubry S., Steele J.W., et al. Characterization and molecular profiling of PSEN1 familial alzheimer&#x2019;s disease iPSC-Derived neural progenitors. PLoS ONE. 2014;9:e84547. doi: 10.1371/journal.pone.0084547.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0084547</ArticleId><ArticleId IdType="pmc">PMC3885572</ArticleId><ArticleId IdType="pubmed">24416243</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujimori K., Ishikawa M., Otomo A., Atsuta N., Nakamura R., Akiyama T., Hadano S., Aoki M., Saya H., Sobue G., et al. Modeling sporadic ALS in iPSC-derived motor neurons identifies a potential therapeutic agent. Nat. Med. 2018;24:1579&#x2013;1589. doi: 10.1038/s41591-018-0140-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-018-0140-5</ArticleId><ArticleId IdType="pubmed">30127392</ArticleId></ArticleIdList></Reference><Reference><Citation>Dimos J.T., Rodolfa K.T., Niakan K.K., Weisenthal L.M., Mitsumoto H., Chung W., Croft G.F., Saphier G., Leibel R., Goland R., et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science. 2008;321:1218&#x2013;1221. doi: 10.1126/science.1158799.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1158799</ArticleId><ArticleId IdType="pubmed">18669821</ArticleId></ArticleIdList></Reference><Reference><Citation>Abud E.M., Ramirez R.N., Martinez E.S., Healy L.M., Nguyen C.H.H., Newman S.A., Yeromin A.V., Scarfone V.M., Marsh S.E., Fimbres C., et al. iPSC-Derived Human Microglia-like Cells to Study Neurological Diseases. Neuron. 2017;94:278&#x2013;293. doi: 10.1016/j.neuron.2017.03.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2017.03.042</ArticleId><ArticleId IdType="pmc">PMC5482419</ArticleId><ArticleId IdType="pubmed">28426964</ArticleId></ArticleIdList></Reference><Reference><Citation>Brownjohn P.W., Smith J., Solanki R., Lohmann E., Houlden H., Hardy J., Dietmann S., Livesey F.J. Functional Studies of Missense TREM2 Mutations in Human Stem Cell-Derived Microglia. Stem Cell Rep. 2018;10:1294&#x2013;1307. doi: 10.1016/j.stemcr.2018.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2018.03.003</ArticleId><ArticleId IdType="pmc">PMC5998752</ArticleId><ArticleId IdType="pubmed">29606617</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez de Maturana R., Lang V., Zubiarrain A., Sousa A., V&#xe1;zquez N., Gorostidi A., &#xc1;guila J., L&#xf3;pez de Munain A., Rodr&#xed;guez M., S&#xe1;nchez-Pernaute R. Mutations in LRRK2 impair NF-&#x39a;B pathway in iPSC-derived neurons. J. Neuroinflamm. 2016;13:295. doi: 10.1186/s12974-016-0761-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-016-0761-x</ArticleId><ArticleId IdType="pmc">PMC5116223</ArticleId><ArticleId IdType="pubmed">27863501</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantle J.L., Lee K.H. A differentiating neural stem cell-derived astrocytic population mitigates the inflammatory effects of TNF-&#x3b1; and IL-6 in an iPSC-based blood-brain barrier model. Neurobiol. Dis. 2018;119:113&#x2013;120. doi: 10.1016/j.nbd.2018.07.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2018.07.030</ArticleId><ArticleId IdType="pubmed">30075293</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantle J.L., Lee K.H. Immunoglobulin G transport increases in an in vitro blood&#x2013;brain barrier model with amyloid-&#x3b2; and with neuroinflammatory cytokines. Biotechnol. Bioeng. 2019;116:1752&#x2013;1761. doi: 10.1002/bit.26967.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bit.26967</ArticleId><ArticleId IdType="pubmed">30883675</ArticleId></ArticleIdList></Reference><Reference><Citation>Trindade P., Loiola E.C., Gasparotto J., Ribeiro C.T., Cardozo P.L., Devalle S., Salerno J.A., Ornelas I.M., Ledur P.F., Ribeiro F.M., et al. Short and long TNF-alpha exposure recapitulates canonical astrogliosis events in human-induced pluripotent stem cells-derived astrocytes. Glia. 2020;68:1396&#x2013;1409. doi: 10.1002/glia.23786.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23786</ArticleId><ArticleId IdType="pubmed">32003513</ArticleId></ArticleIdList></Reference><Reference><Citation>Stebbins M.J., Gastfriend B.D., Canfield S.G., Lee M.-S., Richards D., Faubion M.G., Li W.-J., Daneman R., Palecek S.P., Shusta E.V. Human pluripotent stem cell&#x2013;derived brain pericyte&#x2013;like cells induce blood-brain barrier properties. Sci. Adv. 2019;5:eaau7375. doi: 10.1126/sciadv.aau7375.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.aau7375</ArticleId><ArticleId IdType="pmc">PMC6415958</ArticleId><ArticleId IdType="pubmed">30891496</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamieson J.J., Linville R.M., Ding Y.Y., Gerecht S., Searson P.C. Role of iPSC-derived pericytes on barrier function of iPSC-derived brain microvascular endothelial cells in 2D and 3D. Fluids Barriers CNS. 2019;16:15. doi: 10.1186/s12987-019-0136-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12987-019-0136-7</ArticleId><ArticleId IdType="pmc">PMC6551886</ArticleId><ArticleId IdType="pubmed">31167667</ArticleId></ArticleIdList></Reference><Reference><Citation>Faal T., Phan D.T.T., Davtyan H., Scarfone V.M., Varady E., Blurton-Jones M., Hughes C.C.W., Inlay M.A. Induction of Mesoderm and Neural Crest-Derived Pericytes from Human Pluripotent Stem Cells to Study Blood-Brain Barrier Interactions. Stem Cell Rep. 2019;12:451&#x2013;460. doi: 10.1016/j.stemcr.2019.01.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2019.01.005</ArticleId><ArticleId IdType="pmc">PMC6409424</ArticleId><ArticleId IdType="pubmed">30745035</ArticleId></ArticleIdList></Reference><Reference><Citation>Lippmann E.S., Azarin S.M., Kay J.E., Nessler R.A., Wilson H.K., Al-Ahmad A., Palecek S.P., Shusta E.V. Derivation of blood-brain barrier endothelial cells from human pluripotent stem cells. Nat. Biotechnol. 2012;30:783&#x2013;791. doi: 10.1038/nbt.2247.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.2247</ArticleId><ArticleId IdType="pmc">PMC3467331</ArticleId><ArticleId IdType="pubmed">22729031</ArticleId></ArticleIdList></Reference><Reference><Citation>Lippmann E.S., Al-Ahmad A., Azarin S.M., Palecek S.P., Shusta E.V. A retinoic acid-enhanced, multicellular human blood-brain barrier model derived from stem cell sources. Sci. Rep. 2014;4:4160. doi: 10.1038/srep04160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep04160</ArticleId><ArticleId IdType="pmc">PMC3932448</ArticleId><ArticleId IdType="pubmed">24561821</ArticleId></ArticleIdList></Reference><Reference><Citation>Haenseler W., Sansom S.N., Buchrieser J., Newey S.E., Moore C.S., Nicholls F.J., Chintawar S., Schnell C., Antel J.P., Allen N.D., et al. A Highly Efficient Human Pluripotent Stem Cell Microglia Model Displays a Neuronal-Co-culture-Specific Expression Profile and Inflammatory Response. Stem Cell Rep. 2017;8:1727&#x2013;1742. doi: 10.1016/j.stemcr.2017.05.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2017.05.017</ArticleId><ArticleId IdType="pmc">PMC5470330</ArticleId><ArticleId IdType="pubmed">28591653</ArticleId></ArticleIdList></Reference><Reference><Citation>Yagi T., Ito D., Okada Y., Akamatsu W., Nihei Y., Yoshizaki T., Yamanaka S., Okano H., Suzuki N. Modeling familial Alzheimer&#x2019;s disease with induced pluripotent stem cells. Hum. Mol. Genet. 2011;20:4530&#x2013;4539. doi: 10.1093/hmg/ddr394.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddr394</ArticleId><ArticleId IdType="pubmed">21900357</ArticleId></ArticleIdList></Reference><Reference><Citation>Balez R., Steiner N., Engel M., Mu&#xf1;oz S.S., Lum J.S., Wu Y., Wang D., Vallotton P., Sachdev P., O&#x2019;Connor M., et al. Neuroprotective effects of apigenin against inflammation, neuronal excitability and apoptosis in an induced pluripotent stem cell model of Alzheimer&#x2019;s disease. Sci. Rep. 2016;6:31450. doi: 10.1038/srep31450.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep31450</ArticleId><ArticleId IdType="pmc">PMC4981845</ArticleId><ArticleId IdType="pubmed">27514990</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei Z., Kale S., El Fatimy R., Rabinovsky R., Krichevsky A.M. Co-cultures of glioma stem cells and primary neurons, astrocytes, microglia, and endothelial cells for investigation of intercellular communication in the brain. Front. Neurosci. 2019;13:361. doi: 10.3389/fnins.2019.00361.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00361</ArticleId><ArticleId IdType="pmc">PMC6482299</ArticleId><ArticleId IdType="pubmed">31057356</ArticleId></ArticleIdList></Reference><Reference><Citation>Pabon M.M., Bachstetter A.D., Hudson C.E., Gemma C., Bickford P.C. CX3CL1 reduces neurotoxicity and microglial activation in a rat model of Parkinson&#x2019;s disease. J. Neuroinflamm. 2011;8:9. doi: 10.1186/1742-2094-8-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-8-9</ArticleId><ArticleId IdType="pmc">PMC3039584</ArticleId><ArticleId IdType="pubmed">21266082</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardona A.E., Pioro E.P., Sasse M.E., Kostenko V., Cardona S.M., Dijkstra I.M., Huang D.R., Kidd G., Dombrowski S., Dutta R., et al. Control of microglial neurotoxicity by the fractalkine receptor. Nat. Neurosci. 2006;9:917&#x2013;924. doi: 10.1038/nn1715.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1715</ArticleId><ArticleId IdType="pubmed">16732273</ArticleId></ArticleIdList></Reference><Reference><Citation>Szepesi Z., Manouchehrian O., Bachiller S., Deierborg T. Bidirectional Microglia&#x2013;Neuron Communication in Health and Disease. Front. Cell. Neurosci. 2018;12:323. doi: 10.3389/fncel.2018.00323.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2018.00323</ArticleId><ArticleId IdType="pmc">PMC6170615</ArticleId><ArticleId IdType="pubmed">30319362</ArticleId></ArticleIdList></Reference><Reference><Citation>Gresa-Arribas N., Vi&#xe9;itez C., Dentesano G., Serratosa J., Saura J., Sol&#xe0; C. Modelling Neuroinflammation In Vitro: A Tool to Test the Potential Neuroprotective Effect of Anti-Inflammatory Agents. PLoS ONE. 2012;7:e45227. doi: 10.1371/journal.pone.0045227.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0045227</ArticleId><ArticleId IdType="pmc">PMC3447933</ArticleId><ArticleId IdType="pubmed">23028862</ArticleId></ArticleIdList></Reference><Reference><Citation>Block M.L., Zecca L., Hong J.-S. Microglia-mediated neurotoxicity: Uncovering the molecular mechanisms. Nat. Rev. Neurosci. 2007;8:57&#x2013;69. doi: 10.1038/nrn2038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn2038</ArticleId><ArticleId IdType="pubmed">17180163</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo X.-G., Chen S.-D. The changing phenotype of microglia from homeostasis to disease. Transl. Neurodegener. 2012;1:9. doi: 10.1186/2047-9158-1-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2047-9158-1-9</ArticleId><ArticleId IdType="pmc">PMC3514090</ArticleId><ArticleId IdType="pubmed">23210447</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamynina A.V., Esteras N., Koroev D.O., Bobkova N.V., Balasanyants S.M., Simonyan R.A., Avetisyan A.V., Abramov A.Y., Volpina O.M. Synthetic Fragments of Receptor for Advanced Glycation End Products Bind Beta-Amyloid 1&#x2013;40 and Protect Primary Brain Cells From Beta-Amyloid Toxicity. Front. Neurosci. 2018;12:681. doi: 10.3389/fnins.2018.00681.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.00681</ArticleId><ArticleId IdType="pmc">PMC6170785</ArticleId><ArticleId IdType="pubmed">30319347</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z.J., Ran Y.Y., Qie S.Y., Gong W.J., Gao F.H., Ding Z.T., Xi J.N. Melatonin protects against ischemic stroke by modulating microglia/macrophage polarization toward anti-inflammatory phenotype through STAT3 pathway. CNS Neurosci. Ther. 2019;25:1353&#x2013;1362. doi: 10.1111/cns.13261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cns.13261</ArticleId><ArticleId IdType="pmc">PMC6887673</ArticleId><ArticleId IdType="pubmed">31793209</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y.M., Liu Z.Y., Ai Y.H., Zhang L.N., Zou Y., Peng Q.Y. Blocking the CD38/cADPR pathway plays a double-edged role in LPS stimulated microglia. Neuroscience. 2017;361:34&#x2013;42. doi: 10.1016/j.neuroscience.2017.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2017.08.010</ArticleId><ArticleId IdType="pubmed">28807785</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J.M., Li Q.W., Jiang G.X., Liu J.S., Cheng Q. IL-18 induced IL-23/IL-17 expression impairs A&#x3b2; clearance in cultured THP-1 and BV2 cells. Cytokine. 2019;119:113&#x2013;118. doi: 10.1016/j.cyto.2019.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2019.03.003</ArticleId><ArticleId IdType="pubmed">30903865</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandes A., Ribeiro A.R., Monteiro M., Garcia G., Vaz A.R., Brites D. Secretome from SH-SY5Y APP(Swe) cells trigger time-dependent CHME3 microglia activation phenotypes, ultimately leading to miR-21 exosome shuttling. Biochimie. 2018;155:67&#x2013;82. doi: 10.1016/j.biochi.2018.05.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biochi.2018.05.015</ArticleId><ArticleId IdType="pubmed">29857185</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin P., Wang S., Wei Y., Wang X., Zhang J., Yin X., Feng J., Zhu M. Maresin1 Decreased Microglial Chemotaxis and Ameliorated Inflammation Induced by Amyloid-&#x3b2;42 in Neuron-Microglia Co-Culture Models. J. Alzheimers Dis. 2020;73:503&#x2013;515. doi: 10.3233/JAD-190682.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-190682</ArticleId><ArticleId IdType="pubmed">31796671</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Y.-F., Zhou X., Chang D., Bhuyan D.J., Zhang J.P., Yu W.-Z., Jiang X.-S., Seto S.W., Yeon S.Y., Li J., et al. A novel tri-culture model for neuroinflammation. J. Neurochem. 2021;156:249&#x2013;261. doi: 10.1111/jnc.15171.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.15171</ArticleId><ArticleId IdType="pubmed">32891068</ArticleId></ArticleIdList></Reference><Reference><Citation>Goshi N., Morgan R.K., Lein P.J., Seker E. A primary neural cell culture model to study neuron, astrocyte, and microglia interactions in neuroinflammation. J. Neuroinflamm. 2020;17:115. doi: 10.1186/s12974-020-01819-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-020-01819-z</ArticleId><ArticleId IdType="pmc">PMC7216677</ArticleId><ArticleId IdType="pubmed">32393376</ArticleId></ArticleIdList></Reference><Reference><Citation>Appelt-Menzel A., Cubukova A., G&#xfc;nther K., Edenhofer F., Piontek J., Krause G., St&#xfc;ber T., Walles H., Neuhaus W., Metzger M. Establishment of a Human Blood-Brain Barrier Co-culture Model Mimicking the Neurovascular Unit Using Induced Pluri- and Multipotent Stem Cells. Stem Cell Rep. 2017;8:894&#x2013;906. doi: 10.1016/j.stemcr.2017.02.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2017.02.021</ArticleId><ArticleId IdType="pmc">PMC5390136</ArticleId><ArticleId IdType="pubmed">28344002</ArticleId></ArticleIdList></Reference><Reference><Citation>Lippmann E.S., Weidenfeller C., Svendsen C.N., Shusta E.V. Blood&#x2013;brain barrier modeling with co-cultured neural progenitor cell-derived astrocytes and neurons. J. Neurochem. 2011;119:507&#x2013;520. doi: 10.1111/j.1471-4159.2011.07434.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2011.07434.x</ArticleId><ArticleId IdType="pmc">PMC3192906</ArticleId><ArticleId IdType="pubmed">21854389</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayakawa K., Pham L.D.D., Arai K., Lo E.H. Reactive astrocytes promote adhesive interactions between brain endothelium and endothelial progenitor cells via HMGB1 and beta-2 integrin signaling. Stem Cell Res. 2014:531&#x2013;538. doi: 10.1016/j.scr.2013.12.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scr.2013.12.008</ArticleId><ArticleId IdType="pmc">PMC3966549</ArticleId><ArticleId IdType="pubmed">24480450</ArticleId></ArticleIdList></Reference><Reference><Citation>Manczak M., Calkins M.J., Reddy P.H. Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer&#x2019;s disease: Implications for neuronal damage. Hum. Mol. Genet. 2011;20:2495&#x2013;2509. doi: 10.1093/hmg/ddr139.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddr139</ArticleId><ArticleId IdType="pmc">PMC3109997</ArticleId><ArticleId IdType="pubmed">21459773</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez C., Armijo E., Bravo-Alegria J., Becerra-Calixto A., Mays C.E., Soto C. Modeling amyloid beta and tau pathology in human cerebral organoids. Mol. Psychiatry. 2018;23:2363&#x2013;2374. doi: 10.1038/s41380-018-0229-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-018-0229-8</ArticleId><ArticleId IdType="pmc">PMC6594704</ArticleId><ArticleId IdType="pubmed">30171212</ArticleId></ArticleIdList></Reference><Reference><Citation>Wray S. Modelling neurodegenerative disease using brain organoids. Semin. Cell Dev. Biol. 2021;111:60&#x2013;66. doi: 10.1016/j.semcdb.2020.05.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcdb.2020.05.012</ArticleId><ArticleId IdType="pubmed">32513498</ArticleId></ArticleIdList></Reference><Reference><Citation>Grenier K., Kao J., Diamandis P. Three-dimensional modeling of human neurodegeneration: Brain organoids coming of age. Mol. Psychiatry. 2020;25:254&#x2013;274. doi: 10.1038/s41380-019-0500-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-019-0500-7</ArticleId><ArticleId IdType="pubmed">31444473</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H., Park H.J., Choi H., Chang Y., Park H., Shin J., Kim J., Lengner C.J., Lee Y.K., Kim J. Modeling G2019S-LRRK2 Sporadic Parkinson&#x2019;s Disease in 3D Midbrain Organoids. Stem Cell Rep. 2019;12:518&#x2013;531. doi: 10.1016/j.stemcr.2019.01.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2019.01.020</ArticleId><ArticleId IdType="pmc">PMC6410341</ArticleId><ArticleId IdType="pubmed">30799274</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi S.H., Kim Y.H., Hebisch M., Sliwinski C., Lee S., D&#x2019;Avanzo C., Chen H., Hooli B., Asselin C., Muffat J., et al. A three-dimensional human neural cell culture model of Alzheimer&#x2019;s disease. Nature. 2014;515:274&#x2013;278. doi: 10.1038/nature13800.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature13800</ArticleId><ArticleId IdType="pmc">PMC4366007</ArticleId><ArticleId IdType="pubmed">25307057</ArticleId></ArticleIdList></Reference><Reference><Citation>Mansour A.A., Gon&#xe7;alves J.T., Bloyd C.W., Li H., Fernandes S., Quang D., Johnston S., Parylak S.L., Jin X., Gage F.H. An in vivo model of functional and vascularized human brain organoids. Nat. Biotechnol. 2018 doi: 10.1038/nbt.4127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.4127</ArticleId><ArticleId IdType="pmc">PMC6331203</ArticleId><ArticleId IdType="pubmed">29658944</ArticleId></ArticleIdList></Reference><Reference><Citation>Cakir B., Xiang Y., Tanaka Y., Kural M.H., Parent M., Kang Y.J., Chapeton K., Patterson B., Yuan Y., He C.S., et al. Engineering of human brain organoids with a functional vascular-like system. Nat. Methods. 2019;16:1169&#x2013;1175. doi: 10.1038/s41592-019-0586-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41592-019-0586-5</ArticleId><ArticleId IdType="pmc">PMC6918722</ArticleId><ArticleId IdType="pubmed">31591580</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y.T., Seo J., Gao F., Feldman H.M., Wen H.L., Penney J., Cam H.P., Gjoneska E., Raja W.K., Cheng J., et al. APOE4 Causes Widespread Molecular and Cellular Alterations Associated with Alzheimer&#x2019;s Disease Phenotypes in Human iPSC-Derived Brain Cell Types. Neuron. 2018;98:1141&#x2013;1154. doi: 10.1016/j.neuron.2018.05.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.05.008</ArticleId><ArticleId IdType="pmc">PMC6023751</ArticleId><ArticleId IdType="pubmed">29861287</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor A.M., Blurton-Jones M., Rhee S.W., Cribbs D.H., Cotman C.W., Jeon N.L. A microfluidic culture platform for CNS axonal injury, regeneration and transport. Nat. Methods. 2005;2:599&#x2013;605. doi: 10.1038/nmeth777.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth777</ArticleId><ArticleId IdType="pmc">PMC1558906</ArticleId><ArticleId IdType="pubmed">16094385</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J., Koito H., Li J., Han A. Microfluidic compartmentalized co-culture platform for CNS axon myelination research. Biomed. Microdevices. 2009;11:1145&#x2013;1153. doi: 10.1007/s10544-009-9331-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10544-009-9331-7</ArticleId><ArticleId IdType="pmc">PMC2783938</ArticleId><ArticleId IdType="pubmed">19554452</ArticleId></ArticleIdList></Reference><Reference><Citation>Achyuta A.K.H., Conway A.J., Crouse R.B., Bannister E.C., Lee R.N., Katnik C.P., Behensky A.A., Cuevas J., Sundaram S.S. A modular approach to create a neurovascular unit-on-a-chip. Lab Chip. 2013;13:542&#x2013;553. doi: 10.1039/C2LC41033H.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C2LC41033H</ArticleId><ArticleId IdType="pubmed">23108480</ArticleId></ArticleIdList></Reference><Reference><Citation>Griep L.M., Wolbers F., de Wagenaar B., ter Braak P.M., Weksler B.B., Romero I.A., Couraud P.O., Vermes I., van der Meer A.D., van den Berg A. BBB on chip: Microfluidic platform to mechanically and biochemically modulate blood-brain barrier function. Biomed. Microdevices. 2013;15:145&#x2013;150. doi: 10.1007/s10544-012-9699-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10544-012-9699-7</ArticleId><ArticleId IdType="pubmed">22955726</ArticleId></ArticleIdList></Reference><Reference><Citation>Osaki T., Shin Y., Sivathanu V., Campisi M., Kamm R.D. In Vitro Microfluidic Models for Neurodegenerative Disorders. Adv. Healthc. Mater. 2018;7:1700489. doi: 10.1002/adhm.201700489.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/adhm.201700489</ArticleId><ArticleId IdType="pubmed">28881425</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsatsanis A., McCorkindale A.N., Wong B.X., Patrick E., Ryan T.M., Evans R.W., Bush A.I., Sutherland G.T., Sivaprasadarao A., Guennewig B., et al. The acute phase protein lactoferrin is a key feature of Alzheimer&#x2019;s disease and predictor of A&#x3b2; burden through induction of APP amyloidogenic processing. Mol. Psychiatry. 2021 doi: 10.1038/s41380-021-01248-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-021-01248-1</ArticleId><ArticleId IdType="pmc">PMC8758478</ArticleId><ArticleId IdType="pubmed">34400772</ArticleId></ArticleIdList></Reference><Reference><Citation>Dello Russo C., Cappoli N., Coletta I., Mezzogori D., Paciello F., Pozzoli G., Navarra P., Battaglia A. The human microglial HMC3 cell line: Where do we stand? A systematic literature review. J. Neuroinflamm. 2018;15:259. doi: 10.1186/s12974-018-1288-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-018-1288-0</ArticleId><ArticleId IdType="pmc">PMC6131758</ArticleId><ArticleId IdType="pubmed">30200996</ArticleId></ArticleIdList></Reference><Reference><Citation>Weksler B., Romero I.A., Couraud P.-O. The hCMEC/D3 cell line as a model of the human blood brain barrier. Fluids Barriers CNS. 2013;10:16. doi: 10.1186/2045-8118-10-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2045-8118-10-16</ArticleId><ArticleId IdType="pmc">PMC3623852</ArticleId><ArticleId IdType="pubmed">23531482</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabbani N., Thornalley P.J. Reading patterns of proteome damage by glycation, oxidation and nitration: Quantitation by stable isotopic dilution analysis LC-MS/MS. Essays Biochem. 2020;64:169&#x2013;183. doi: 10.1042/EBC20190047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/EBC20190047</ArticleId><ArticleId IdType="pubmed">32065835</ArticleId></ArticleIdList></Reference><Reference><Citation>Thornalley P.J., Rabbani N. Detection of oxidized and glycated proteins in clinical samples using mass spectrometry&#x2014;A user&#x2019;s perspective. Biochim. Biophys. Acta -Gen. Subj. 2014;1840:818&#x2013;829. doi: 10.1016/j.bbagen.2013.03.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbagen.2013.03.025</ArticleId><ArticleId IdType="pubmed">23558060</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Der Lugt T., Weseler A.R., Gebbink W.A., Vrolijk M.F., Opperhuizen A., Bast A. Dietary advanced glycation endproducts induce an inflammatory response in human macrophages in vitro. Nutrients. 2018;10:1868. doi: 10.3390/nu10121868.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu10121868</ArticleId><ArticleId IdType="pmc">PMC6315629</ArticleId><ArticleId IdType="pubmed">30513810</ArticleId></ArticleIdList></Reference><Reference><Citation>Soboleva A., Vikhnina M., Grishina T., Frolov A. Probing Protein Glycation by Chromatography and Mass Spectrometry: Analysis of Glycation Adducts. Int. J. Mol. Sci. 2017;18:2557. doi: 10.3390/ijms18122557.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms18122557</ArticleId><ArticleId IdType="pmc">PMC5751160</ArticleId><ArticleId IdType="pubmed">29182540</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang G., Huang G., Xiao L., Mitchell A.E. Determination of advanced glycation endproducts by LC-MS/MS in raw and roasted almonds (Prunus dulcis) J. Agric. Food Chem. 2011;59:12037&#x2013;12046. doi: 10.1021/jf202515k.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jf202515k</ArticleId><ArticleId IdType="pubmed">21980977</ArticleId></ArticleIdList></Reference><Reference><Citation>Lapolla A., Fedele D., Reitano R., Aric&#xf2; N.C., Seraglia R., Traldi P., Marotta E., Tonani R. Enzymatic digestion and mass spectrometry in the study of advanced glycation end products/peptides. J. Am. Soc. Mass Spectrom. 2004;15:496&#x2013;509. doi: 10.1016/j.jasms.2003.11.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jasms.2003.11.014</ArticleId><ArticleId IdType="pubmed">15047055</ArticleId></ArticleIdList></Reference><Reference><Citation>Reznikov L.L., Waksman J., Azam T., Kim S.H., Bufler P., Niwa T., Werman A., Zhang X., Pischetsrieder M., Shaldon S., et al. Effect of advanced glycation end products on endotoxin-induced TNF-alpha, IL-1beta and IL-8 in human peripheral blood mononuclear cells. Clin. Nephrol. 2004;61:324&#x2013;336. doi: 10.5414/CNP61324.</Citation><ArticleIdList><ArticleId IdType="doi">10.5414/CNP61324</ArticleId><ArticleId IdType="pubmed">15182127</ArticleId></ArticleIdList></Reference><Reference><Citation>Buetler T.M., Latado H., Leclerc E., Weigle B., Baumeyer A., Heizmann C.W., Scholz G. Glycolaldehyde-modified &#x3b2;-lactoglobulin AGEs are unable to stimulate inflammatory signaling pathways in RAGE-expressing human cell lines. Mol. Nutr. Food Res. 2011;55:291&#x2013;299. doi: 10.1002/mnfr.201000140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mnfr.201000140</ArticleId><ArticleId IdType="pubmed">20715095</ArticleId></ArticleIdList></Reference><Reference><Citation>Buetler T.M., Leclerc E., Baumeyer A., Latado H., Newell J., Adolfsson O., Parisod V., Richoz J., Maurer S., Foata F., et al. N&#x3b5;-carboxymethyllysine-modified proteins are unable to bind to RAGE and activate an inflammatory response. Mol. Nutr. Food Res. 2008;52:370&#x2013;378. doi: 10.1002/mnfr.200700101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mnfr.200700101</ArticleId><ArticleId IdType="pubmed">18320574</ArticleId></ArticleIdList></Reference><Reference><Citation>Teodorowicz M., Perdijk O., Verhoek I., Govers C., Savelkoul H.F.J., Tang Y., Wichers H., Broersen K. Optimized Triton X-114 assisted lipopolysaccharide (LPS) removal method reveals the immunomodulatory effect of food proteins. PLoS ONE. 2017;12:e0173778. doi: 10.1371/journal.pone.0173778.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0173778</ArticleId><ArticleId IdType="pmc">PMC5371287</ArticleId><ArticleId IdType="pubmed">28355240</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>